1
|
Jurescu A, Văduva A, Vița O, Gheju A, Cornea R, Lăzureanu C, Mureșan A, Cornianu M, Tăban S, Dema A. Colorectal Carcinomas: Searching for New Histological Parameters Associated with Lymph Node Metastases. Medicina (Kaunas) 2023; 59:1761. [PMID: 37893479 PMCID: PMC10608479 DOI: 10.3390/medicina59101761] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/25/2023] [Revised: 09/21/2023] [Accepted: 09/28/2023] [Indexed: 10/29/2023]
Abstract
Background and Objectives: Colorectal cancer (CRC) continues to be an essential public health problem. Our study aimed to evaluate the prognostic significance of classic prognostic factors and some less-studied histopathological parameters in CRC. Materials and Methods: We performed a retrospective study on 71 colorectal carcinoma patients who underwent surgery at the "Pius Brînzeu" County Clinical Emergency Hospital in Timișoara, Romania. We analyzed the classic parameters but also tumor budding (TB), poorly differentiated clusters (PDCs) of cells, tumor-infiltrating lymphocytes (TILs), and the configuration of the tumor border on hematoxylin-eosin slides. Results: A high degree of malignancy (p = 0.006), deep invasion of the intestinal wall (p = 0.003), an advanced stage of the disease (p < 0.0001), lymphovascular invasion (p < 0.0001), perineural invasion (p < 0.0001), high-grade TB (p < 0.0001), high-grade PDCs (p < 0.0001), infiltrative tumor border configuration (p < 0.0001) showed a positive correlation with lymph node metastases. Conclusions: The analyzed parameters positively correlate with unfavorable prognostic factors in CRC. We highlight the value of classic prognostic factors along with a series of less-known parameters that are more accessible and easier to evaluate using standard staining techniques and that could predict the risk of relapse or aggressive evolution in patients with CRC.
Collapse
Affiliation(s)
- Aura Jurescu
- Department of Microscopic Morphology-Morphopathology, ANAPATMOL Research Center, “Victor Babeş” University of Medicine and Pharmacy, 300041 Timișoara, Romania
| | - Adrian Văduva
- Department of Microscopic Morphology-Morphopathology, ANAPATMOL Research Center, “Victor Babeş” University of Medicine and Pharmacy, 300041 Timișoara, Romania
- Department of Pathology, “Pius Brînzeu” County Clinical Emergency Hospital, 300723 Timişoara, Romania
| | - Octavia Vița
- Department of Microscopic Morphology-Morphopathology, ANAPATMOL Research Center, “Victor Babeş” University of Medicine and Pharmacy, 300041 Timișoara, Romania
| | - Adelina Gheju
- Emergency County Hospital Deva, 330032 Deva, Romania
| | - Remus Cornea
- Department of Microscopic Morphology-Morphopathology, ANAPATMOL Research Center, “Victor Babeş” University of Medicine and Pharmacy, 300041 Timișoara, Romania
- Department of Pathology, “Pius Brînzeu” County Clinical Emergency Hospital, 300723 Timişoara, Romania
| | - Codruța Lăzureanu
- Department of Microscopic Morphology-Morphopathology, ANAPATMOL Research Center, “Victor Babeş” University of Medicine and Pharmacy, 300041 Timișoara, Romania
- Department of Pathology, “Pius Brînzeu” County Clinical Emergency Hospital, 300723 Timişoara, Romania
| | - Anca Mureșan
- Department of Microscopic Morphology-Morphopathology, ANAPATMOL Research Center, “Victor Babeş” University of Medicine and Pharmacy, 300041 Timișoara, Romania
- Department of Pathology, “Pius Brînzeu” County Clinical Emergency Hospital, 300723 Timişoara, Romania
| | - Marioara Cornianu
- Department of Microscopic Morphology-Morphopathology, ANAPATMOL Research Center, “Victor Babeş” University of Medicine and Pharmacy, 300041 Timișoara, Romania
- Department of Pathology, “Pius Brînzeu” County Clinical Emergency Hospital, 300723 Timişoara, Romania
| | - Sorina Tăban
- Department of Microscopic Morphology-Morphopathology, ANAPATMOL Research Center, “Victor Babeş” University of Medicine and Pharmacy, 300041 Timișoara, Romania
- Department of Pathology, “Pius Brînzeu” County Clinical Emergency Hospital, 300723 Timişoara, Romania
| | - Alis Dema
- Department of Microscopic Morphology-Morphopathology, ANAPATMOL Research Center, “Victor Babeş” University of Medicine and Pharmacy, 300041 Timișoara, Romania
- Department of Pathology, “Pius Brînzeu” County Clinical Emergency Hospital, 300723 Timişoara, Romania
| |
Collapse
|
2
|
Popa O, Barna RA, Borlea A, Cornianu M, Dema A, Stoian D. The impact of the COVID-19 pandemic on thyroid nodular disease: a retrospective study in a single center in the western part of Romania. Front Endocrinol (Lausanne) 2023; 14:1221795. [PMID: 37497351 PMCID: PMC10368367 DOI: 10.3389/fendo.2023.1221795] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/12/2023] [Accepted: 06/23/2023] [Indexed: 07/28/2023] Open
Abstract
Introduction The COVID-19 pandemic had a significant impact on the healthcare system, leading to a prioritization of hospital admissions in many countries. Romania was no exception, and it had to restrict patient access to medical services in hospitals with chronic diseases and oncological pathology, including thyroid cancer. This study aimed to compare the clinical and pathological factors of patients with nodular thyroid disease diagnosed and surgically treated during the two years before and after the COVID-19 pandemic, in a single medical institution. Methods The retrospective study included 1505 patients who were diagnosed and operated on for nodular thyroid disease between January 2018 and December 2021. The patients were divided into two groups: the "PRECOVID" group (January 2018 to February 2020), and the "POSTCOVID" group (March 2020 to December 2021). The analyzed parameters included patients' gender, age, preoperative diagnosis, type of surgical intervention, and pathological diagnosis. Results A significant decrease was observed in the number of surgeries performed for thyroid nodular disease during the COVID-19 pandemic period (450 versus 1055 cases, p<0.00001). There was a significant decrease in the number of surgical reinterventions (0.9% in the POSTCOVID group versus 2.9% in the PRECOVID group, p=0.01) and a significant increase in the number of total thyroidectomies (84.9% in the POSTCOVID group versus 80.1% in the PRECOVID group, p=0.02). We also observed a higher incidence of malignant/borderline tumors in the POSTCOVID group compared to the PRECOVID group (p=0.04) and a significantly higher frequency of aggressive forms of thyroid cancer in the POSTCOVID group (p=0.0006). Discussion The COVID-19 pandemic had a significant impact on the surgical management of nodular thyroid disease, resulting in a decrease in surgeries and a change in the type of surgical interventions performed. The higher incidence of malignant/borderline tumors diagnosed during the pandemic highlights the importance of timely diagnosis and treatment of thyroid nodules to prevent cancer progression.
Collapse
Affiliation(s)
- Oana Popa
- Endocrinology Department, Centre of Molecular Research in Nephrology and Vascular Disease, University of Medicine and Pharmacy “Victor Babes”, Timisoara, Romania
| | - Robert Alexandru Barna
- Discipline of Morphopathology, Department of Microscopic Morphology, ANAPATMOL Research Centre, University of Medicine and Pharmacy “Victor Babes”, Timisoara, Romania
| | - Andreea Borlea
- Endocrinology Department, Centre of Molecular Research in Nephrology and Vascular Disease, University of Medicine and Pharmacy “Victor Babes”, Timisoara, Romania
| | - Marioara Cornianu
- Discipline of Morphopathology, Department of Microscopic Morphology, ANAPATMOL Research Centre, University of Medicine and Pharmacy “Victor Babes”, Timisoara, Romania
| | - Alis Dema
- Discipline of Morphopathology, Department of Microscopic Morphology, ANAPATMOL Research Centre, University of Medicine and Pharmacy “Victor Babes”, Timisoara, Romania
| | - Dana Stoian
- Endocrinology Department, Centre of Molecular Research in Nephrology and Vascular Disease, University of Medicine and Pharmacy “Victor Babes”, Timisoara, Romania
| |
Collapse
|
3
|
Vița O, Jurescu A, Văduva A, Cornea R, Cornianu M, Tăban S, Szilagyi D, Micșescu C, Natarâș B, Dema A. Invasive Cutaneous Melanoma: Evaluating the Prognostic Significance of Some Parameters Associated with Lymph Node Metastases. Medicina (Kaunas) 2023; 59:1241. [PMID: 37512052 PMCID: PMC10385614 DOI: 10.3390/medicina59071241] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/18/2023] [Revised: 06/27/2023] [Accepted: 06/30/2023] [Indexed: 07/30/2023]
Abstract
Background and Objectives: This study aimed to assess the clinical-pathological profile of patients with invasive cutaneous melanomas and to identify the parameters with a prognostic role in the lymph nodal spread of this malignant tumor. Materials and Methods: We performed a retrospective study on patients with invasive cutaneous melanomas who underwent surgery in the "Pius Brînzeu" County Clinical Emergency Hospital from Timișoara, Romania, and were evaluated for the status of loco-regional lymph nodes. We selected and analyzed some parameters searching for their relationship with lymph node metastases. Results: We identified 79 patients with invasive cutaneous melanomas (29 men and 50 women, mean age 59.36 years). A percentage of 58.3% of melanomas had Breslow tumor thickness >2 mm; 69.6% of melanomas showed a Clark level IV-V. Tumor ulceration was present in 59.5% of melanomas. A mitotic rate of ≥5 mitoses/mm2 was observed in 48.1% of melanomas. Tumor-infiltrating lymphocytes (TILs), non-brisk, were present in 59.5% of cases and 22.8% of patients had satellite/in-transit metastasis (SINTM). Tumor regression was identified in 44.3% of cases. Lymph nodes metastases were found in 43.1% of patients. Statistical analysis showed that lymph node metastases were more frequent in melanomas with Breslow thickness >2 mm (p = 0.0002), high Clark level (p = 0.0026), mitotic rate >5 mitoses/mm2 (p = 0.0044), ulceration (p = 0.0107), lymphovascular invasion (p = 0.0182), SINTM (p = 0.0302), and non-brisk TILs (p = 0.0302). Conclusions: The Breslow thickness >2 mm, high Clark level, high mitotic rate and ulceration are the most important prognostic factors for lymph nodal spread in cutaneous melanomas. However, some melanomas without these clinical-pathological features can have an unexpected, aggressive evolution, which entails the necessity of close and prolonged clinical follow-up of patients, including those with lesions considered without risk.
Collapse
Affiliation(s)
- Octavia Vița
- Department of Microscopic Morphology-Morphopatology, ANAPATMOL Research Center, "Victor Babeș" University of Medicine and Pharmacy, 300041 Timișoara, Romania
| | - Aura Jurescu
- Department of Microscopic Morphology-Morphopatology, ANAPATMOL Research Center, "Victor Babeș" University of Medicine and Pharmacy, 300041 Timișoara, Romania
| | - Adrian Văduva
- Department of Microscopic Morphology-Morphopatology, ANAPATMOL Research Center, "Victor Babeș" University of Medicine and Pharmacy, 300041 Timișoara, Romania
- Department of Pathology, "Pius Brînzeu" County Clinical Emergency Hospital, 300723 Timișoara, Romania
| | - Remus Cornea
- Department of Microscopic Morphology-Morphopatology, ANAPATMOL Research Center, "Victor Babeș" University of Medicine and Pharmacy, 300041 Timișoara, Romania
- Department of Pathology, "Pius Brînzeu" County Clinical Emergency Hospital, 300723 Timișoara, Romania
| | - Marioara Cornianu
- Department of Microscopic Morphology-Morphopatology, ANAPATMOL Research Center, "Victor Babeș" University of Medicine and Pharmacy, 300041 Timișoara, Romania
- Department of Pathology, "Pius Brînzeu" County Clinical Emergency Hospital, 300723 Timișoara, Romania
| | - Sorina Tăban
- Department of Microscopic Morphology-Morphopatology, ANAPATMOL Research Center, "Victor Babeș" University of Medicine and Pharmacy, 300041 Timișoara, Romania
- Department of Pathology, "Pius Brînzeu" County Clinical Emergency Hospital, 300723 Timișoara, Romania
| | - Diana Szilagyi
- Department of Pathology, "Pius Brînzeu" County Clinical Emergency Hospital, 300723 Timișoara, Romania
| | - Cristian Micșescu
- Department of Microscopic Morphology-Morphopatology, ANAPATMOL Research Center, "Victor Babeș" University of Medicine and Pharmacy, 300041 Timișoara, Romania
| | - Bianca Natarâș
- Department of Microscopic Morphology-Morphopatology, ANAPATMOL Research Center, "Victor Babeș" University of Medicine and Pharmacy, 300041 Timișoara, Romania
- Department of Pathology, "Pius Brînzeu" County Clinical Emergency Hospital, 300723 Timișoara, Romania
| | - Alis Dema
- Department of Microscopic Morphology-Morphopatology, ANAPATMOL Research Center, "Victor Babeș" University of Medicine and Pharmacy, 300041 Timișoara, Romania
- Department of Pathology, "Pius Brînzeu" County Clinical Emergency Hospital, 300723 Timișoara, Romania
| |
Collapse
|
4
|
Oprean CM, Ciocoiu AD, Segarceanu NA, Moldoveanu D, Stan A, Hoinoiu T, Chiorean-Cojocaru I, Grujic D, Stefanut A, Pit D, Dema A. Pregnancy in a Young Patient with Metastatic HER2-Positive Breast Cancer-Between Fear of Recurrence and Desire to Procreate. Curr Oncol 2023; 30:4833-4843. [PMID: 37232822 DOI: 10.3390/curroncol30050364] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/14/2023] [Revised: 05/01/2023] [Accepted: 05/06/2023] [Indexed: 05/27/2023] Open
Abstract
Breast cancer is the most frequent neoplasm among women and the second leading cause of death by cancer. It is the most frequent cancer diagnosed during pregnancy. Pregnancy-associated breast cancer is defined as breast cancer that is diagnosed during pregnancy and/or in the postpartum period. Data about young women with metastatic HER2-positive cancer who desire a pregnancy are scarce. The medical attitude in these clinical situations is difficult and nonstandardized. We present the case of a 31-year-old premenopausal woman diagnosed in December 2016 with a stage IV Luminal HER2-positive metastatic breast cancer (pT2 N0 M1 hep). The patient was initially treated by surgery in a conservative manner. Postoperatively, the presence of liver metastases was found by CT investigation. Consequently, line I treatment (docetaxel l75 mg/m² iv; trastuzumab 600 mg/5 mL sq) and ovarian drug suppression (Goserelin 3.6 mg sq at 28 days) was administered. After nine cycles of treatment, the patient's liver metastases had a partial response to the therapy. Despite having a favorable disease evolution and a strong desire to procreate, the patient vehemently refused to continue any oncological treatment. The psychiatric consult highlighted an anxious and depressive reaction for which individual and couple psychotherapy sessions were recommended. After 10 months from the interruption of the oncological treatment, the patient appeared with an evolving pregnancy of 15 weeks. An abdominal ultrasound revealed the presence of multiple liver metastases. Knowing all the possible effects, the patient consciously decided to postpone the proposed second-line treatment. In August 2018, the patient was admitted in the emergency department with malaise, diffuse abdominal pain and hepatic failure. Abdominal ultrasound found a 21-week-old pregnancy which had stopped in evolution, multiple liver metastases and ascites in large quantity. She was transferred to the ICU department where she perished just a few hours later. Conclusions/Discussion: From a psychological standpoint, the patient had an emotional hardship to make the transition from the status of a healthy person to the status of a sick person. Consequently, she entered a process of emotional protection of the positive cognitive distortion type, which favored the decision to abandon treatment and try to complete the pregnancy to the detriment of her own survival. The patient delayed the initiation of oncological treatment in pregnancy until it was too late. The consequence of this delay in treatment led to the death of the mother and fetus. A multidisciplinary team worked to provide this patient with the best medical care and psychological assistance throughout the course of the disease.
Collapse
Affiliation(s)
- Cristina Marinela Oprean
- ANAPATMOL Research Center, 'Victor Babes' University of Medicine and Pharmacy of Timisoara, 300041 Timisoara, Romania
- Department of Oncology, ONCOHELP Hospital Timisoara, Ciprian Porumbescu Street, No. 59, 300239 Timisoara, Romania
- Department of Oncology, ONCOMED Outpatient Unit, Ciprian Porumbescu Street, No. 59, 300239 Timisoara, Romania
| | - Andrei Dorin Ciocoiu
- Department of Oncology, ONCOHELP Hospital Timisoara, Ciprian Porumbescu Street, No. 59, 300239 Timisoara, Romania
| | - Nusa Alina Segarceanu
- Department of Oncology, ONCOHELP Hospital Timisoara, Ciprian Porumbescu Street, No. 59, 300239 Timisoara, Romania
- Department of Oncology, ONCOMED Outpatient Unit, Ciprian Porumbescu Street, No. 59, 300239 Timisoara, Romania
| | - Diana Moldoveanu
- Department of Oncology, ONCOHELP Hospital Timisoara, Ciprian Porumbescu Street, No. 59, 300239 Timisoara, Romania
- Department of Oncology, ONCOMED Outpatient Unit, Ciprian Porumbescu Street, No. 59, 300239 Timisoara, Romania
| | - Alexandra Stan
- Department of Oncology, City Clinical Emergency Hospital of Timisoara, Victor Babes Blvd. No. 22, 300595 Timisoara, Romania
| | - Teodora Hoinoiu
- Department of Clinical Practical Skills, "Victor Babes" University of Medicine and Pharmacy, Eftimie Murgu Sq. Nr. 2, 300041 Timisoara, Romania
- Center for Advanced Research in Cardiovascular Pathology and Hemostaseology, "Victor Babes" University of Medicine and Pharmacy, 300041 Timisoara, Romania
| | - Ioana Chiorean-Cojocaru
- Department of Obstetrics and Gynaecology, Faculty of Medicine and Pharmacy, "Victor Babes" University of Medicine and Pharmacy, 300041 Timisoara, Romania
| | - Daciana Grujic
- Department of Plastic and Reconstructive Surgery, "Victor Babes" University of Medicine and Pharmacy, Eftimie Murgu Sq. Nr. 2, 300041 Timisoara, Romania
| | - Adelina Stefanut
- Department of Psichology & Sociology, West University, Timisora, Blvd. No. 4, Vasile Pârvan, 300223 Timisoara, Romania
| | - Daniel Pit
- Center for Advanced Research in Cardiovascular Pathology and Hemostaseology, "Victor Babes" University of Medicine and Pharmacy, 300041 Timisoara, Romania
| | - Alis Dema
- ANAPATMOL Research Center, 'Victor Babes' University of Medicine and Pharmacy of Timisoara, 300041 Timisoara, Romania
| |
Collapse
|
5
|
Maralescu FM, Vaduva A, Schiller A, Petrica L, Sporea I, Popescu A, Sirli R, Dema A, Bodea M, Grosu I, Bob F. Relationship between Novel Elastography Techniques and Renal Fibrosis-Preliminary Experience in Patients with Chronic Glomerulonephritis. Biomedicines 2023; 11:biomedicines11020365. [PMID: 36830901 PMCID: PMC9953735 DOI: 10.3390/biomedicines11020365] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/28/2022] [Revised: 01/21/2023] [Accepted: 01/24/2023] [Indexed: 01/28/2023] Open
Abstract
INTRODUCTION A renal biopsy represents the gold standard in the diagnosis, prognosis, and management of patients with glomerulonephritis. So far, non-invasive elastographic techniques have not confirmed their utility in replacing a biopsy; however, the new and improved software from Hologic Supersonic Mach 30 is a promising method for assessing the renal tissue's stiffness and viscosity. We investigated whether this elastography technique could reveal renal tissue fibrosis in patients with chronic glomerulonephritis. MATERIALS AND METHODS Two-dimensional-shear wave elastography (SWE) PLUS and viscosity plane-wave ultrasound (Vi PLUS) assessments were performed in 40 patients with chronic glomerulopathies before being referred for a renal biopsy. For each kidney, the mean values of five stiffness and viscosity measures were compared with the demographic, biological, and histopathological parameters of the patients. RESULTS In total, 26 men and 14 women with a mean age of 52.35 ± 15.54 years, a mean estimated glomerular filtration rate (eGFR) of 53.8 ± 35.49 mL/min/1.73m2, and a mean proteinuria of 6.39 ± 7.42 g/24 h were included after providing their informed consent. Out of 40 kidney biopsies, 2 were uninterpretable with inappropriate material and were divided into four subgroups based on their fibrosis percentage. Even though these elastography techniques were unable to differentiate between separate fibrosis stages, when predicting between the fibrosis and no-fibrosis group, we found a cut-off value of <20.77 kPa with the area under the curve (AUC) of 0.860, a p < 0.001 with 88.89% sensitivity, and a 75% specificity for the 2D SWE PLUS measures and a cut-off value of <2.8 Pa.s with an AUC of 0.792, a p < 0.001 with 94% sensitivity, and a 60% specificity for the Vi PLUS measures. We also found a cut-off value of <19.75 kPa for the 2D SWE PLUS measures (with an AUC of 0.789, p = 0.0001 with 100% sensitivity, and a 74.29% specificity) and a cut-off value of <1.28 Pa.s for the Vi PLUS measures (with an AUC 0.829, p = 0.0019 with 60% sensitivity, and a 94.29% specificity) differentiating between patients with over 40% fibrosis and those with under 40%. We also discovered a positive correlation between the glomerular filtration rate (eGFR) and 2D-SWE PLUS values (r = 0.7065, p < 0.0001) and Vi PLUS values (r = 0.3637, p < 0.0211). C reactive protein (CRP) correlates with the Vi PLUS measures (r = -0.3695, p = 0.0189) but not with the 2D SWE PLUS measures (r = -0.2431, p = 0.1306). CONCLUSION Our findings indicate that this novel elastography method can distinguish between individuals with different stages of renal fibrosis, correlate with the renal function and inflammation, and are easy to use and reproducible, but further research is needed for them to be employed routinely in clinical practice.
Collapse
Affiliation(s)
- Felix-Mihai Maralescu
- Division of Nephrology, Department of Internal Medicine II, Victor Babeș University of Medicine and Pharmacy, 300041 Timisoara, Romania
- Centre for Molecular Research in Nephrology and Vascular Disease, Victor Babeș University of Medicine and Pharmacy, 300041 Timisoara, Romania
- County Emergency Hospital, L. Rebreanu Street, Nr. 156, 300723 Timisoara, Romania
| | - Adrian Vaduva
- County Emergency Hospital, L. Rebreanu Street, Nr. 156, 300723 Timisoara, Romania
- ANAPATMOL Research Centre, Discipline of Morphopathology, Department of Microscopic Morphology, Victor Babes University of Medicine and Pharmacy, 300041 Timisoara, Romania
- Discipline of Morphopathology, Department of Microscopic Morphology, Faculty of Medicine, Victor Babes University of Medicine and Pharmacy, 300041 Timisoara, Romania
- Correspondence:
| | - Adalbert Schiller
- Division of Nephrology, Department of Internal Medicine II, Victor Babeș University of Medicine and Pharmacy, 300041 Timisoara, Romania
- Centre for Molecular Research in Nephrology and Vascular Disease, Victor Babeș University of Medicine and Pharmacy, 300041 Timisoara, Romania
- County Emergency Hospital, L. Rebreanu Street, Nr. 156, 300723 Timisoara, Romania
| | - Ligia Petrica
- Division of Nephrology, Department of Internal Medicine II, Victor Babeș University of Medicine and Pharmacy, 300041 Timisoara, Romania
- Centre for Molecular Research in Nephrology and Vascular Disease, Victor Babeș University of Medicine and Pharmacy, 300041 Timisoara, Romania
- County Emergency Hospital, L. Rebreanu Street, Nr. 156, 300723 Timisoara, Romania
| | - Ioan Sporea
- County Emergency Hospital, L. Rebreanu Street, Nr. 156, 300723 Timisoara, Romania
- Department of Gastroenterology and Hepatology, Victor Babeș University of Medicine and Pharmacy, 300041 Timisoara, Romania
- Advanced Regional Research Center in Gastroenterology and Hepatology, Victor Babeș University of Medicine and Pharmacy, 300041 Timisoara, Romania
| | - Alina Popescu
- County Emergency Hospital, L. Rebreanu Street, Nr. 156, 300723 Timisoara, Romania
- Department of Gastroenterology and Hepatology, Victor Babeș University of Medicine and Pharmacy, 300041 Timisoara, Romania
- Advanced Regional Research Center in Gastroenterology and Hepatology, Victor Babeș University of Medicine and Pharmacy, 300041 Timisoara, Romania
| | - Roxana Sirli
- County Emergency Hospital, L. Rebreanu Street, Nr. 156, 300723 Timisoara, Romania
- Department of Gastroenterology and Hepatology, Victor Babeș University of Medicine and Pharmacy, 300041 Timisoara, Romania
- Advanced Regional Research Center in Gastroenterology and Hepatology, Victor Babeș University of Medicine and Pharmacy, 300041 Timisoara, Romania
| | - Alis Dema
- County Emergency Hospital, L. Rebreanu Street, Nr. 156, 300723 Timisoara, Romania
- ANAPATMOL Research Centre, Discipline of Morphopathology, Department of Microscopic Morphology, Victor Babes University of Medicine and Pharmacy, 300041 Timisoara, Romania
- Discipline of Morphopathology, Department of Microscopic Morphology, Faculty of Medicine, Victor Babes University of Medicine and Pharmacy, 300041 Timisoara, Romania
| | - Madalina Bodea
- Division of Nephrology, Department of Internal Medicine II, Victor Babeș University of Medicine and Pharmacy, 300041 Timisoara, Romania
- Centre for Molecular Research in Nephrology and Vascular Disease, Victor Babeș University of Medicine and Pharmacy, 300041 Timisoara, Romania
- County Emergency Hospital, L. Rebreanu Street, Nr. 156, 300723 Timisoara, Romania
| | - Iulia Grosu
- Division of Nephrology, Department of Internal Medicine II, Victor Babeș University of Medicine and Pharmacy, 300041 Timisoara, Romania
- Centre for Molecular Research in Nephrology and Vascular Disease, Victor Babeș University of Medicine and Pharmacy, 300041 Timisoara, Romania
- County Emergency Hospital, L. Rebreanu Street, Nr. 156, 300723 Timisoara, Romania
| | - Flaviu Bob
- Division of Nephrology, Department of Internal Medicine II, Victor Babeș University of Medicine and Pharmacy, 300041 Timisoara, Romania
- Centre for Molecular Research in Nephrology and Vascular Disease, Victor Babeș University of Medicine and Pharmacy, 300041 Timisoara, Romania
- County Emergency Hospital, L. Rebreanu Street, Nr. 156, 300723 Timisoara, Romania
| |
Collapse
|
6
|
Rațiu I, Lupușoru R, Lungeanu D, Popescu A, Sporea I, Goldiș A, Dănilă M, Miuțescu B, Moga T, Barbulescu A, Tăban S, Dema A, Șirli R. Diagnosis of malignant biliary obstruction: pondering over the ERCP, MRCP and histology. J Int Med Res 2022; 50:3000605221076924. [PMID: 35170356 PMCID: PMC8855398 DOI: 10.1177/03000605221076924] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022] Open
Abstract
Objective To compare the diagnostic accuracy of endoscopic retrograde
cholangiopancreatography (ERCP), magnetic resonance pancreatography (MRCP)
and histological examination for malignant biliary obstruction. Methods This retrospective study included patients admitted for biliary obstruction
caused by biliary tree malignancy that underwent ERCP, MRCP and histological
examination. Data were collected from the medical records. The primary
endpoints were the area under the receiver operating characteristic (AUROC)
curve value, sensitivity, specificity and overall diagnostic accuracy of the
three procedures in terms of a final diagnosis of obstructive biliary
malignancy; and the agreement between ERCP, MRCP and histological
examination with the final diagnosis. Results A total of 160 patients were included in the study (85 males, 53.1%;
mean ± SD age, 69.31 ± 10.96 years). Considering the final diagnosis, the
performance of MRCP, ERCP and histology in assessing biliary tumours
produced AUROC values of 0.88 (95% confidence interval [CI] 0.75, 0.90),
0.94 (95% CI 0.85, 0.99) and 0.80 (95% CI 0.70, 0.82), respectively. ERCP
presented higher sensitivity, overall diagnostic accuracy and agreement with
the final diagnosis than MRCP and histological examination. Conclusion These current data suggest that invasive methods such as ERCP with biopsy
remain more reliable than non-invasive methods.
Collapse
Affiliation(s)
- Iulia Rațiu
- Advanced Regional Research Centre in Gastroenterology and Hepatology, Department of Internal Medicine II, Discipline of Gastroenterology and Hepatology, "Victor Babes" University of Medicine and Pharmacy Timisoara, Romania
| | - Raluca Lupușoru
- Advanced Regional Research Centre in Gastroenterology and Hepatology, Department of Internal Medicine II, Discipline of Gastroenterology and Hepatology, "Victor Babes" University of Medicine and Pharmacy Timisoara, Romania.,Centre for Modelling Biological Systems and Data Analysis, Department of Functional Sciences, "Victor Babes" University of Medicine and Pharmacy Timisoara, Romania
| | - Diana Lungeanu
- Centre for Modelling Biological Systems and Data Analysis, Department of Functional Sciences, "Victor Babes" University of Medicine and Pharmacy Timisoara, Romania
| | - Alina Popescu
- Advanced Regional Research Centre in Gastroenterology and Hepatology, Department of Internal Medicine II, Discipline of Gastroenterology and Hepatology, "Victor Babes" University of Medicine and Pharmacy Timisoara, Romania
| | - Ioan Sporea
- Advanced Regional Research Centre in Gastroenterology and Hepatology, Department of Internal Medicine II, Discipline of Gastroenterology and Hepatology, "Victor Babes" University of Medicine and Pharmacy Timisoara, Romania
| | - Adrian Goldiș
- Advanced Regional Research Centre in Gastroenterology and Hepatology, Department of Internal Medicine II, Discipline of Gastroenterology and Hepatology, "Victor Babes" University of Medicine and Pharmacy Timisoara, Romania
| | - Mirela Dănilă
- Advanced Regional Research Centre in Gastroenterology and Hepatology, Department of Internal Medicine II, Discipline of Gastroenterology and Hepatology, "Victor Babes" University of Medicine and Pharmacy Timisoara, Romania
| | - Bogdan Miuțescu
- Advanced Regional Research Centre in Gastroenterology and Hepatology, Department of Internal Medicine II, Discipline of Gastroenterology and Hepatology, "Victor Babes" University of Medicine and Pharmacy Timisoara, Romania
| | - Tudor Moga
- Advanced Regional Research Centre in Gastroenterology and Hepatology, Department of Internal Medicine II, Discipline of Gastroenterology and Hepatology, "Victor Babes" University of Medicine and Pharmacy Timisoara, Romania
| | - Andreea Barbulescu
- Advanced Regional Research Centre in Gastroenterology and Hepatology, Department of Internal Medicine II, Discipline of Gastroenterology and Hepatology, "Victor Babes" University of Medicine and Pharmacy Timisoara, Romania
| | - Sorina Tăban
- ANAPATMOL Research Centre, Discipline of Morphopathology, Department of Microscopic Morphology, "Victor Babes" University of Medicine and Pharmacy Timisoara, Romania
| | - Alis Dema
- ANAPATMOL Research Centre, Discipline of Morphopathology, Department of Microscopic Morphology, "Victor Babes" University of Medicine and Pharmacy Timisoara, Romania
| | - Roxana Șirli
- Advanced Regional Research Centre in Gastroenterology and Hepatology, Department of Internal Medicine II, Discipline of Gastroenterology and Hepatology, "Victor Babes" University of Medicine and Pharmacy Timisoara, Romania
| |
Collapse
|
7
|
Oprean CM, Badau LM, Han RA, Hoinoiu T, Dragomir GM, Grujic D, Dragomir T, Dema A. The Pattern of Second Primary Tumours in Postmenopausal Women with Prior Breast Cancer in Western Romania: A Retrospective, Single-Institution Study. Diagnostics (Basel) 2021; 11:diagnostics11111957. [PMID: 34829304 PMCID: PMC8622918 DOI: 10.3390/diagnostics11111957] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/30/2021] [Revised: 09/27/2021] [Accepted: 10/13/2021] [Indexed: 12/02/2022] Open
Abstract
With improved survival, more patients with prior breast cancer are at risk of having a second primary cancer diagnosed. The pattern and impact of second primary cancers following breast cancer is important for overall breast cancer therapeutic management. Our study is a first analysis of the trend of second primary tumours over time in terms of incidence, sites with significantly elevated risks and correlation with stage, molecular subtype and therapeutic strategies conducted in Eastern Europe in postmenopausal women with breast cancer. Patients and methods: Our study population included 28 patients with prior breast cancer (BC) and second primary tumours, which were diagnosed and treated in our Institution between 2004 and 2017. The criteria for selection were based on the completeness of the documentation of the first treatment for breast cancer, stage of disease, molecular subtype, the site of origin of the second tumours and the survival data. Results: An increased risk of second primary cancer was associated with the 51–60 years age group (53.6%), with the greater prevalence in patients living in urban environments (82.1%). The use of chemotherapy increased the risk of the occurrence of gynecological second malignancies (75%). Our study is a first analysis of the trend of second primary tumours over time in terms of identifying sites with significantly elevated risks and correlation with therapeutic strategies conducted in Eastern Europe in postmenopausal women with breast cancer. Conclusions: Our study is a first analysis of the trend of second primary tumours over time in terms of correlation with luminal subtype and stage at diagnosis of primary cancer sites with significantly elevated risks and correlation with therapeutic strategies in postmenopausal women with breast cancer conducted in Eastern Europe. The reported time from primary to second primary malignancy onset, with a significantly higher rate for postmenopausal breast cancer patients, was less than one year (50%). With the advances and wider availability of genetic testing (e.g., gene panels), patients diagnosed with multiple primaries should be increasingly investigated for an underlying cancer predisposition. Postmenopausal women with breast cancer may benefit from increased surveillance and advice to avoid second malignancies.
Collapse
Affiliation(s)
- Cristina Marinela Oprean
- ANAPATMOL Research Center, ‘Victor Babes’ University of Medicine and Pharmacy of Timisoara, 300041 Timisoara, Romania; (C.M.O.); (A.D.)
- Department of Oncology—ONCOHELP Hospital Timisoara, Ciprian Porumbescu Street, No. 59, 300239 Timisoara, Romania; (L.M.B.); (R.-A.H.)
- Department of Oncology—ONCOMED Outpatient Unit Timisoara, Ciprian Porumbescu Street, No. 59, 300239 Timisoara, Romania
| | - Larisa Maria Badau
- Department of Oncology—ONCOHELP Hospital Timisoara, Ciprian Porumbescu Street, No. 59, 300239 Timisoara, Romania; (L.M.B.); (R.-A.H.)
- Hygiene Discipline, “Victor Babeş” University of Medicine and Pharmacy, Eftimie Murgu Square Nr.2, 300041 Timişoara, Romania
| | - Robert-Alexandru Han
- Department of Oncology—ONCOHELP Hospital Timisoara, Ciprian Porumbescu Street, No. 59, 300239 Timisoara, Romania; (L.M.B.); (R.-A.H.)
| | - Teodora Hoinoiu
- Department of Clinical Practical Skills, “Victor Babeş” University of Medicine and Pharmacy, Eftimie Murgu Square Nr.2, 300041 Timişoara, Romania
- Center for Advanced Research in Cardiovascular Pathology and Hemostaseology, “Victor Babeș” University of Medicine and Pharmacy, 300041 Timisoara, Romania
- Correspondence: ; Tel.: +40-0256-204-400
| | - Gabriel-Mugur Dragomir
- Department of Teaching Training—POLYTEHNICAL, University of Timisoara, 300223 Timisoara, Romania;
| | - Daciana Grujic
- Department of Plastic and Reconstructive Surgery, “Victor Babeş” University of Medicine and Pharmacy, Eftimie Murgu Square Nr.2, 300041 Timişoara, Romania;
| | - Tiberiu Dragomir
- Department V Internal Medicine, Discipline of Medical Semiology II, “Victor Babes” University of Medicine and Pharmacy, Eftimie Murgu Square Nr.2, 300041 Timisoara, Romania;
| | - Alis Dema
- ANAPATMOL Research Center, ‘Victor Babes’ University of Medicine and Pharmacy of Timisoara, 300041 Timisoara, Romania; (C.M.O.); (A.D.)
| |
Collapse
|
8
|
Jurescu A, Dema A, Văduva A, Gheju A, Vița O, Barna R, Lăzureanu C, Cornianu M, Tăban S, Duță C, Pantea S. Poorly differentiated clusters and tumor budding are important prognostic factors in colorectal carcinomas. Bosn J Basic Med Sci 2021; 22:164-177. [PMID: 34480464 PMCID: PMC8977077 DOI: 10.17305/bjbms.2021.6110] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/04/2021] [Accepted: 08/27/2021] [Indexed: 11/16/2022] Open
Abstract
The aim of our study was to assess the prognostic value of the two new grading systems based on the quantification of tumor budding - TB (GBd) and poorly differentiated clusters - PDCs (PDCs-G) in colorectal carcinomas (CRC). We performed a retrospective study on 71 CRC patients who underwent surgery at the Emergency County Hospital, Timișoara. CRC cases were classified based on haematoxylin-eosin slides, using the conventional grading system, GBd and PDCs-G, respectively. We used two-tier and three-tier grading schemes for each system. Subsequently, we evaluated associations with other prognostic factors in CRC. Based on the three-tier GBd (GBd-3t) most cases (34/69, 49.27%) were classified as G3Bd-3t, while based on the conventional grading system, the majority of the cases (55/69, 79.71%) were considered G2. On the other hand, based on the three-tier PDCs-G system (PDCs-G-3t), most cases (31/69, 44.93%) were PDCs-G2-3t. We also noted a more significant association of GBd-3t with other prognostic parameters analyzed, as compared to the conventional grading system. Nodal status, tumor stage, and lymphovascular invasion were strongly correlated with GBd-3t (p=0.0001). Furthermore, we noted that PDCs-G-3t correlated more significantly than the conventional grading system with nodal status (p<0.0001), tumor stage (p=0.0003), lymphovascular invasion (p<0.0001), perineural invasion (p=0.005) and the tumor border configuration (p<0.0001). High GBd and PDCs-G grades correlate directly with other negative prognostic factors in CRC.Thus, these new parameters/classification methods could be used as additional tools for risk stratification in patients with CRC.
Collapse
Affiliation(s)
- Aura Jurescu
- Department of Microscopic Morphology - Morphopathology, ANAPATMOL Research Center, "Victor Babeş" University of Medicine and Pharmacy, Timișoara
| | - Alis Dema
- Department of Microscopic Morphology - Morphopathology, ANAPATMOL Research Center, "Victor Babeş" University of Medicine and Pharmacy, Timișoara, Romania; 2 Department of Pathology, "Pius Brînzeu" County Clinical Emergency Hospital, Timişoara, Romania
| | - Adrian Văduva
- Department of Microscopic Morphology - Morphopathology, ANAPATMOL Research Center, "Victor Babeş" University of Medicine and Pharmacy, Timișoara, Romania; 2Department of Pathology, "Pius Brînzeu" County Clinical Emergency Hospital, Timişoara, Romania
| | - Adelina Gheju
- Department of Microscopic Morphology - Morphopathology, ANAPATMOL Research Center, "Victor Babeş" University of Medicine and Pharmacy, Timișoara, Romania
| | - Octavia Vița
- 1 Department of Microscopic Morphology - Morphopathology, ANAPATMOL Research Center, "Victor Babeş" University of Medicine and Pharmacy, Timișoara, Romania
| | - Robert Barna
- Department of Microscopic Morphology - Morphopathology, ANAPATMOL Research Center, "Victor Babeş" University of Medicine and Pharmacy, Timișoara, Romania; 2 Department of Pathology, "Pius Brînzeu" County Clinical Emergency Hospital, Timişoara, Romania
| | - Codruța Lăzureanu
- Department of Microscopic Morphology - Morphopathology, ANAPATMOL Research Center, "Victor Babeş" University of Medicine and Pharmacy, Timișoara, Romania; 2 Department of Pathology, "Pius Brînzeu" County Clinical Emergency Hospital, Timişoara, Romania
| | - Marioara Cornianu
- Department of Microscopic Morphology - Morphopathology, ANAPATMOL Research Center, "Victor Babeş" University of Medicine and Pharmacy, Timișoara, Romania; 2 Department of Pathology, "Pius Brînzeu" County Clinical Emergency Hospital, Timişoara, Romania
| | - Sorina Tăban
- Department of Microscopic Morphology - Morphopathology, ANAPATMOL Research Center, "Victor Babeş" University of Medicine and Pharmacy, Timișoara, Romania; 2 Department of Pathology, "Pius Brînzeu" County Clinical Emergency Hospital, Timişoara, Romania
| | - Ciprian Duță
- Department of Surgery II, "Victor Babeş" University of Medicine and Pharmacy, Timișoara, Romania; 4 Department of Surgery II, "Pius Brînzeu" County Clinical Emergency Hospital, Timişoara, Romania
| | - Stelian Pantea
- Department of Surgery II, "Victor Babeş" University of Medicine and Pharmacy, Timișoara, Romania; 5 Department of Surgery III, "Pius Brînzeu" County Clinical Emergency Hospital, Timişoara, Romania
| |
Collapse
|
9
|
Gheju A, Jurescu A, Tăban S, Al-Jobory D, Lazăr F, Dema A. Different disease characteristics in young patients with colorectal cancer: a large retrospective study in a city in Romania. J Int Med Res 2021; 49:3000605211016630. [PMID: 34034541 PMCID: PMC8161876 DOI: 10.1177/03000605211016630] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/08/2023] Open
Abstract
OBJECTIVE In 2018, colorectal cancer (CRC) was the second most frequent malignancy in Romania after lung cancer. Although CRC is typically encountered in patients >50 years old, CRC's global incidence among younger adults has been increasing. We aimed to compare the disease characteristics of patients with CRC aged ≤50 years with those >50 years old. METHODS We retrospectively evaluated data from patients with CRC who underwent standard surgery at "Pius Brinzeu" Emergency County Hospital, Timisoara, Romania. Patients were divided into two groups: Group 1 (patients ≤50 years old) and Group 2 (patients >50 years old). Six parameters were analyzed (sex, residence location, age, tumor localization, microscopic findings, pathological staging). RESULTS Data on age-related CRC were available for 1380 patients treated from January 2012 to December 2018. Group 1 included 120 patients while group 2 included 1260 patients. Significantly more Group 1 patients presented with advanced CRC compared with Group 2 patients (94.2% vs. 87.4%). Furthermore, CRC in younger adults was more likely to be diagnosed at an advanced stage. CONCLUSIONS Monitoring the CRC incidence in younger adults is essential to assess whether screening practices require changes and to raise awareness among clinicians of the increasing CRC incidence among younger patients.
Collapse
Affiliation(s)
- Adelina Gheju
- Department of Pathology, "Victor Babes" University of Medicine and Pharmacy, Timisoara, Romania
| | - Aura Jurescu
- Department of Pathology, "Victor Babes" University of Medicine and Pharmacy, Timisoara, Romania
| | - Sorina Tăban
- Department of Pathology, "Victor Babes" University of Medicine and Pharmacy, Timisoara, Romania.,Department of Pathology, Emergency Clinical County Hospital "Pius Brinzeu", Timisoara, Romania
| | - Diana Al-Jobory
- Department of Surgery II, Emergency Clinical County Hospital "Pius Brinzeu", Timisoara, Romania
| | - Fulger Lazăr
- Department of Surgery II, Emergency Clinical County Hospital "Pius Brinzeu", Timisoara, Romania.,Department of Surgery II, "Victor Babes" University of Medicine and Pharmacy, Timisoara, Romania
| | - Alis Dema
- Department of Pathology, "Victor Babes" University of Medicine and Pharmacy, Timisoara, Romania.,Department of Pathology, Emergency Clinical County Hospital "Pius Brinzeu", Timisoara, Romania
| |
Collapse
|
10
|
Oprean CM, Badau LM, Segarceanu NA, Ciocoiu AD, Rivis IA, Vornicu VN, Hoinoiu T, Grujic D, Bredicean C, Dema A. Unilateral Orbital Metastasis as the Unique Symptom in the Onset of Breast Cancer in a Postmenopausal Woman: Case Report and Review of the Literature. Diagnostics (Basel) 2021; 11:725. [PMID: 33921735 PMCID: PMC8073535 DOI: 10.3390/diagnostics11040725] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/16/2021] [Revised: 04/09/2021] [Accepted: 04/13/2021] [Indexed: 01/08/2023] Open
Abstract
The orbit represents an unusual metastases site for patients diagnosed with cancer, however, breast cancer is the main cause of metastases at this level. These orbital metastases were discovered in patients with a history of breast cancer as unique or synchronous lesions. We present a rare case of a unique retroocular metastasis as the first initial symptom of a tubulo-lobular mammary carcinoma in a postmenopausal woman. A 57-year-old patient complains of diplopia, diminishing visual acuity, orbital tenderness, slight exophthalmia and ptosis of the left eyelid, with insidious onset. Clinical examination and subsequent investigations revealed a left breast cancer cT2 cN1 pM1 stage IV. Breast conserving surgery was performed on the left breast. Pathological examination with immunohistochemistry staining established the complete diagnostic: pT2pN3aM1 Stage IV breast cancer, luminal B subtype. After two years from the initial breast cancer diagnosis, the patient was diagnosed by the psychiatrist with a depressive disorder and was treated accordingly. Orbital metastases are usually discovered in known breast cancer patients and they are found in the context of a multi-system end-stage disease. Most reports cite that up to 25% of the total orbital metastases cases are discovered before the diagnosis of the primary tumor, as our case did. MRI is the gold standard for evaluating orbital tumors. The ILC histological subtype metastasizes in the orbitals more frequently than invasive ductal carcinoma. The prognosis of patients with orbital metastases is poor. The median survival after diagnosis of orbital metastases from a breast cancer primary is ranging from 22 to 31 months. Overall survival of our patient was 56 months, longer than the median survival reported in literature. Orbital metastases must be taken into account when patients accuse ophthalmologic symptoms even in the absence of a personal history of cancer. Objective examination of every patient that incriminates these types of symptoms is essential, and breast palpation must be made in every clinical setting. Orbital biopsy is necessary for the confirmation of the diagnosis and for an adequate treatment. Although recommendations for management of orbital metastases are controversial, it appears that multidisciplinary treatment of both metastases and primary cancer improves overall survival.
Collapse
Affiliation(s)
- Cristina Marinela Oprean
- Morphopathology Department, “Victor Babeş” University of Medicine and Pharmacy, Eftimie Murgu Sq. Nr.2, 300041 Timişoara, Romania; (C.M.O.); (A.D.)
- Department of Oncology—ONCOHELP Hospital Timisoara, Ciprian Porumbescu Street, No. 59, 300239 Timisoara, Romania; (L.M.B.); (N.A.S.); (A.D.C.); (V.N.V.)
- Department of Oncology—ONCOMED Outpatient Unit Timisoara, Ciprian Porumbescu Street, No. 59, 300239 Timisoara, Romania
| | - Larisa Maria Badau
- Department of Oncology—ONCOHELP Hospital Timisoara, Ciprian Porumbescu Street, No. 59, 300239 Timisoara, Romania; (L.M.B.); (N.A.S.); (A.D.C.); (V.N.V.)
- Hygiene Department, “Victor Babeş” University of Medicine and Pharmacy, Eftimie Murgu Sq. No.2, 300041 Timişoara, Romania
| | - Nusa Alina Segarceanu
- Department of Oncology—ONCOHELP Hospital Timisoara, Ciprian Porumbescu Street, No. 59, 300239 Timisoara, Romania; (L.M.B.); (N.A.S.); (A.D.C.); (V.N.V.)
- Department of Oncology—ONCOMED Outpatient Unit Timisoara, Ciprian Porumbescu Street, No. 59, 300239 Timisoara, Romania
| | - Andrei Dorin Ciocoiu
- Department of Oncology—ONCOHELP Hospital Timisoara, Ciprian Porumbescu Street, No. 59, 300239 Timisoara, Romania; (L.M.B.); (N.A.S.); (A.D.C.); (V.N.V.)
| | - Ioana Alexandra Rivis
- Neurosciences Department, “Carol Davila” University of Medicine and Pharmacy of Bucharest, 020021 Bucharest, Romania;
| | - Vlad Norin Vornicu
- Department of Oncology—ONCOHELP Hospital Timisoara, Ciprian Porumbescu Street, No. 59, 300239 Timisoara, Romania; (L.M.B.); (N.A.S.); (A.D.C.); (V.N.V.)
- Neurosurgery Department, “Victor Babeş” University of Medicine and Pharmacy, Eftimie Murgu Sq. Nr.2, 300041 Timişoara, Romania
| | - Teodora Hoinoiu
- Department of Clinical Practical Skills, “Victor Babeş” University of Medicine and Pharmacy, Eftimie Murgu Sq. Nr.2, 300041 Timişoara, Romania
- Clinic of Burns, Plastic and Reconstructive Surgery, “Pius Branzeu” Emergency County Hospital, 300041 Timisoara, Romania;
| | - Daciana Grujic
- Clinic of Burns, Plastic and Reconstructive Surgery, “Pius Branzeu” Emergency County Hospital, 300041 Timisoara, Romania;
- Department of Plastic and Reconstructive Surgery, “Victor Babeş” University of Medicine and Pharmacy, Eftimie Murgu Sq. Nr.2, 300041 Timişoara, Romania
| | - Cristina Bredicean
- Department of Psychiatry, “Victor Babeş” University of Medicine and Pharmacy, Eftimie Murgu Sq. Nr.2, 300041 Timişoara, Romania;
| | - Alis Dema
- Morphopathology Department, “Victor Babeş” University of Medicine and Pharmacy, Eftimie Murgu Sq. Nr.2, 300041 Timişoara, Romania; (C.M.O.); (A.D.)
| |
Collapse
|
11
|
Borlea A, Dobrescu A, Dema A, Cornianu M, Lazăr FO, Brebu D. Presurgical Stratification of Thyroid Nodules - Is it really Needed? Current Guidelines versus Real Life. Chirurgia (Bucur) 2021; 116:66-74. [PMID: 33638328 DOI: 10.21614/chirurgia.116.1.66] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 02/01/2021] [Indexed: 11/23/2022]
Abstract
Background: Thyroid surgery has various benign and malignant indications. A complete pre-surgical evaluation guides the selection of cases and determines the appropriate extent of the intervention. Minimizing the number of unneeded thyroidectomies could reduce hospitalization costs, as well as post-surgery complications and iatrogenic hypothyroidism. The aim of this study was to retrospectively evaluate the presenting reasons of patients admitted to the hospital for thyroid surgeries and to estimate the need of total thyroidectomies. Methodology: The study included patients admitted in all three Surgical Departments in Timisoara Emergency County Hospital, between January 1st 2018 and December 31st 2019 (2 years). Results: A number of 1036 thyroid surgeries had been performed in 1027 patients and were retrospectively analyzed, comparing the pre-surgical diagnosis with the pathology report. Suspicion of malignancy, compression or functional autonomy was described in 326 /824 total thyroidectomy cases. Cancer was detected in 338 out of the 1027 patients (32.92%), including 39 borderline lesions. A proportion of 80.7% were papillary thyroid cancers. The current presurgical evaluation generated a number of 475 cases displaying differences between the presurgical and postsurgical diagnostic. The phenomenon was observed both in total thyroidectomy and in lobectomy interventions: 22.8% of the lobectomies were diagnosed with thyroid cancer. Conclusion: Our findings confirm that a reliable multidisciplinary approach with standardized presurgical clinical, biochemical and ultrasound evaluation is crucial in patients with indication for thyroid surgery, in order to avoid unnecessary surgeries.
Collapse
|
12
|
Nitusca D, Marcu A, Dema A, Balacescu L, Balacescu O, Bardan R, Cumpanas AA, Sirbu IO, Petrut B, Seclaman E, Marian C. Long Noncoding RNA NEAT1 as a Potential Candidate Biomarker for Prostate Cancer. Life (Basel) 2021; 11:life11040320. [PMID: 33917553 PMCID: PMC8067529 DOI: 10.3390/life11040320] [Citation(s) in RCA: 6] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/18/2021] [Revised: 04/01/2021] [Accepted: 04/05/2021] [Indexed: 11/18/2022] Open
Abstract
Background: Prostate cancer (PCa) remains one of the leading causes of cancer-related mortality in men worldwide, mainly due to unsatisfactory diagnostic methods used at present, which lead to overdiagnosis, unnecessary biopsies and treatment, or misdiagnosis in early asymptomatic stages. New diagnostic biomarkers are needed for a correct and early diagnosis. Long noncoding RNAs (lncRNAs) have been broadly studied for their involvement in PCa biology, as well as for their potential role as diagnostic biomarkers. Methods: We conducted lncRNA profiling in plasma and microdissected formalin-fixed paraffin-embedded (FFPE) tissues of PCa patients and attempted validation for commonly dysregulated individual lncRNAs. Results: Plasma profiling revealed eight dysregulated lncRNAs, while microarray analysis revealed 717 significantly dysregulated lncRNAs, out of which only nuclear-enriched abundant transcript 1 (NEAT1) was commonly upregulated in plasma samples and FFPE tissues. NEAT1’s individual validation revealed statistically significant upregulation (FC = 2.101, p = 0.009). Receiver operating characteristic (ROC) analysis showed an area under the curve (AUC) value of 0.7298 for NEAT1 (95% CI = 0.5812–0.8785), suggesting a relatively high diagnostic value, thus having a potential biomarker role for this malignancy. Conclusions: We present herein data suggesting that NEAT1 could serve as a diagnostic biomarker for PCa. Additional studies of larger cohorts are needed to confirm our findings, as well as the oncogenic mechanism of NEAT1 in the development of PCa.
Collapse
Affiliation(s)
- Diana Nitusca
- Department of Biochemistry and Pharmacology, “Victor Babeş” University of Medicine and Pharmacy, Pta Eftimie Murgu Nr. 2, 300041 Timişoara, Romania; (D.N.); (A.M.); (I.O.S.); (E.S.)
| | - Anca Marcu
- Department of Biochemistry and Pharmacology, “Victor Babeş” University of Medicine and Pharmacy, Pta Eftimie Murgu Nr. 2, 300041 Timişoara, Romania; (D.N.); (A.M.); (I.O.S.); (E.S.)
| | - Alis Dema
- Department of Pathology, “Victor Babeş” University of Medicine and Pharmacy, Pta Eftimie Murgu Nr. 2, 300041 Timişoara, Romania;
| | - Loredana Balacescu
- Department of Genetics, Genomics and Experimental Pathology, The Oncology Institute “Prof. Dr. Ion Chiricuta”, 400015 Cluj-Napoca, Romania; (L.B.); (O.B.)
| | - Ovidiu Balacescu
- Department of Genetics, Genomics and Experimental Pathology, The Oncology Institute “Prof. Dr. Ion Chiricuta”, 400015 Cluj-Napoca, Romania; (L.B.); (O.B.)
| | - Razvan Bardan
- Department of Urology, “Victor Babeş” University of Medicine and Pharmacy, Pta Eftimie Murgu Nr. 2, 300041 Timişoara, Romania; (R.B.); (A.A.C.)
- Urology Clinic, Timisoara Emergency County Hospital, 300723 Timisoara, Romania
| | - Alin Adrian Cumpanas
- Department of Urology, “Victor Babeş” University of Medicine and Pharmacy, Pta Eftimie Murgu Nr. 2, 300041 Timişoara, Romania; (R.B.); (A.A.C.)
- Urology Clinic, Timisoara Emergency County Hospital, 300723 Timisoara, Romania
| | - Ioan Ovidiu Sirbu
- Department of Biochemistry and Pharmacology, “Victor Babeş” University of Medicine and Pharmacy, Pta Eftimie Murgu Nr. 2, 300041 Timişoara, Romania; (D.N.); (A.M.); (I.O.S.); (E.S.)
| | - Bogdan Petrut
- Department of Urology, The Oncology Institute “Prof. Dr. Ion Chiricuta”, 400015 Cluj-Napoca, Romania;
| | - Edward Seclaman
- Department of Biochemistry and Pharmacology, “Victor Babeş” University of Medicine and Pharmacy, Pta Eftimie Murgu Nr. 2, 300041 Timişoara, Romania; (D.N.); (A.M.); (I.O.S.); (E.S.)
| | - Catalin Marian
- Department of Biochemistry and Pharmacology, “Victor Babeş” University of Medicine and Pharmacy, Pta Eftimie Murgu Nr. 2, 300041 Timişoara, Romania; (D.N.); (A.M.); (I.O.S.); (E.S.)
- Correspondence:
| |
Collapse
|
13
|
Hofman P, Ilié M, Chamorey E, Brest P, Schiappa R, Nakache V, Antoine M, Barberis M, Begueret H, Bibeau F, Bonnetaud C, Boström P, Brousset P, Bubendorf L, Carvalho L, Cathomas G, Cazes A, Chalabreysse L, Chenard MP, Copin MC, Côté JF, Damotte D, de Leval L, Delongova P, Thomas de Montpreville V, de Muret A, Dema A, Dietmaier W, Evert M, Fabre A, Forest F, Foulet A, Garcia S, Garcia-Martos M, Gibault L, Gorkiewicz G, Jonigk D, Gosney J, Hofman A, Kern I, Kerr K, Kossai M, Kriegsmann M, Lassalle S, Long-Mira E, Lupo A, Mamilos A, Matěj R, Meilleroux J, Ortiz-Villalón C, Panico L, Panizo A, Papotti M, Pauwels P, Pelosi G, Penault-Llorca F, Pop O, Poté N, Cajal SRY, Sabourin JC, Salmon I, Sajin M, Savic-Prince S, Schildhaus HU, Schirmacher P, Serre I, Shaw E, Sizaret D, Stenzinger A, Stojsic J, Thunnissen E, Timens W, Troncone G, Werlein C, Wolff H, Berthet JP, Benzaquen J, Marquette CH, Hofman V, Calabrese F. Clinical and molecular practice of European thoracic pathology laboratories during the COVID-19 pandemic. The past and the near future. ESMO Open 2020; 6:100024. [PMID: 33399086 PMCID: PMC7780004 DOI: 10.1016/j.esmoop.2020.100024] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/15/2020] [Revised: 11/19/2020] [Accepted: 11/21/2020] [Indexed: 12/18/2022] Open
Abstract
Background This study evaluated the consequences in Europe of the COVID-19 outbreak on pathology laboratories orientated toward the diagnosis of thoracic diseases. Materials and methods A survey was sent to 71 pathology laboratories from 21 European countries. The questionnaire requested information concerning the organization of biosafety, the clinical and molecular pathology, the biobanking, the workload, the associated research into COVID-19, and the organization of education and training during the COVID-19 crisis, from 15 March to 31 May 2020, compared with the same period in 2019. Results Questionnaires were returned from 53/71 (75%) laboratories from 18 European countries. The biosafety procedures were heterogeneous. The workload in clinical and molecular pathology decreased dramatically by 31% (range, 3%-55%) and 26% (range, 7%-62%), respectively. According to the professional category, between 28% and 41% of the staff members were not present in the laboratories but did teleworking. A total of 70% of the laboratories developed virtual meetings for the training of residents and junior pathologists. During the period of study, none of the staff members with confirmed COVID-19 became infected as a result of handling samples. Conclusions The COVID-19 pandemic has had a strong impact on most of the European pathology laboratories included in this study. Urgent implementation of several changes to the organization of most of these laboratories, notably to better harmonize biosafety procedures, was noted at the onset of the pandemic and maintained in the event of a new wave of infection occurring in Europe. Biosafety measures used in the first wave of the COVID-19 crisis were heterogeneous in 53 European pathology laboratories. A dramatic decrease of the workload in pathology laboratories was noted. No case of healthcare workers contaminated with SARS-CoV-2 associated with samples handling was identified.
Collapse
Affiliation(s)
- P Hofman
- Laboratory of Clinical and Experimental Pathology, FHU OncoAge, BB-0033-00025, Louis Pasteur Hospital, IRCAN, Université Côte d'Azur, Nice, France.
| | - M Ilié
- Laboratory of Clinical and Experimental Pathology, FHU OncoAge, BB-0033-00025, Louis Pasteur Hospital, IRCAN, Université Côte d'Azur, Nice, France
| | - E Chamorey
- Epidemiology and Biostatistics Unit, Centre Antoine-Lacassagne, Université Côte d'Azur, Nice, France
| | - P Brest
- Team 4, IRCAN, INSERM, CNRS, Centre Antoine-Lacassagne, Université Côte d'Azur, Nice, France
| | - R Schiappa
- Epidemiology and Biostatistics Unit, Centre Antoine-Lacassagne, Université Côte d'Azur, Nice, France
| | - V Nakache
- Laboratory of Clinical and Experimental Pathology, FHU OncoAge, BB-0033-00025, Louis Pasteur Hospital, IRCAN, Université Côte d'Azur, Nice, France
| | - M Antoine
- Department of Pathology, Hôpital Tenon, AP-HP, Paris, France
| | - M Barberis
- Unit of Histopathology and Molecular Diagnostics, Division of Pathology, IEO, European Institute of Oncology, IRCCS, Milan, Italy
| | - H Begueret
- Department of Pathology, University Hospital of Bordeaux, Bordeaux, France
| | - F Bibeau
- Department of Pathology, CHU de Caen, Université de Caen Normandie, Caen, France
| | - C Bonnetaud
- Laboratory of Clinical and Experimental Pathology, FHU OncoAge, BB-0033-00025, Louis Pasteur Hospital, IRCAN, Université Côte d'Azur, Nice, France
| | - P Boström
- Department of Pathology, Turku University Hospital, Turku, Finland
| | - P Brousset
- Department of Pathology, IUC-T-Oncopole, Inserm U1037 CRCT, Université de Toulouse, Toulouse, France
| | - L Bubendorf
- Institute of Pathology, Institute of Medical Genetics and Pathology, University Hospital Basel, Basel, Switzerland
| | - L Carvalho
- Institute of Anatomical and Molecular Pathology and University Hospital, University of Coimbra, Coimbra, Portugal
| | - G Cathomas
- Institute of Pathology, Cantonal Hospital Baselland, Liestal, Switzerland
| | - A Cazes
- Department of Pathology, Bichat Hospital, AP-HP, Inserm UMR 1152, Université de Paris, Paris, France
| | - L Chalabreysse
- Department of Pathology, Groupement Hospitalier Est, Hospices Civils de Lyon, Lyon, France
| | - M-P Chenard
- Department of Pathology, University Hospital of Strasbourg, Strasbourg, France
| | - M-C Copin
- Institut de Pathologie, CHU Lille, Université de Lille, Lille, France
| | - J-F Côté
- Department of Pathology, Institut Mutualiste Montsouris, Paris, France
| | - D Damotte
- Department of Pathology, Hôpitaux Universitaires Paris Centre, Hôpital Cochin, Inserm U1138, Université de Paris, Paris, France
| | - L de Leval
- Institute of Pathology, Department of Laboratory Medicine and Pathology, Lausanne University Hospital and Lausanne University, Lausanne, Switzerland
| | - P Delongova
- Institute of Pathology, University Hospital Ostrava, Ostrava, Czech Republic
| | | | - A de Muret
- Department of Pathology, University Hospital of Tours, Tours, France
| | - A Dema
- Department of Pathology, Victor Babes University of Medicine and Pharmacy, Timisoara, Romania
| | - W Dietmaier
- Institute of Pathology, University of Regensburg, Regensburg, Germany
| | - M Evert
- Institute of Pathology, University of Regensburg, Regensburg, Germany
| | - A Fabre
- Department of Histopathology, St Vincent's University Hospital, University College Dublin School of Medicine, Dublin, Ireland
| | - F Forest
- Department of Pathology, University Hospital of Saint-Etienne, Saint-Etienne, France
| | - A Foulet
- Department of Pathology, Centre Hospitalier, Le Mans, France
| | - S Garcia
- Department of Pathology, Hôpital Nord, AP-HM, Aix Marseille University, Marseille, France
| | - M Garcia-Martos
- Pulmonary Pathology Department, Gregorio Marañon University Hospital, Madrid, Spain
| | - L Gibault
- Department of Pathology, Hôpital Européen Georges Pompidou, AP-HP, Université de Paris, Paris, France
| | - G Gorkiewicz
- Institute of Pathology, Medical University of Graz, Graz, Austria
| | - D Jonigk
- Institute of Pathology, German Center for Lung Research, Biomedical Research in Endstage and Obstructive Lung Disease Hannover, Hannover Medical School, Hannover, Germany
| | - J Gosney
- Liverpool University Hospitals, Royal Liverpool University Hospital, Liverpool, UK
| | - A Hofman
- Laboratory of Clinical and Experimental Pathology, FHU OncoAge, BB-0033-00025, Louis Pasteur Hospital, IRCAN, Université Côte d'Azur, Nice, France
| | - I Kern
- Department of Pathology, University Clinic Golnik, Golnik, Slovenia
| | - K Kerr
- Department of Pathology, Aberdeen Royal Infirmary, Aberdeen, UK
| | - M Kossai
- Department of Pathology and Molecular Pathology, Centre Jean Perrin, Clermont-Ferrand, France
| | - M Kriegsmann
- Institute of Pathology, University Hospital Heidelberg, Heidelberg, and German Center for Lung Research (DZL), Germany
| | - S Lassalle
- Laboratory of Clinical and Experimental Pathology, FHU OncoAge, BB-0033-00025, Louis Pasteur Hospital, IRCAN, Université Côte d'Azur, Nice, France
| | - E Long-Mira
- Laboratory of Clinical and Experimental Pathology, FHU OncoAge, BB-0033-00025, Louis Pasteur Hospital, IRCAN, Université Côte d'Azur, Nice, France
| | - A Lupo
- Department of Pathology, Hôpitaux Universitaires Paris Centre, Hôpital Cochin, Inserm U1138, Université de Paris, Paris, France
| | - A Mamilos
- Institute of Pathology, University of Regensburg, Regensburg, Germany
| | - R Matěj
- Department of Pathology and Molecular Medicine, Third Faculty of Medicine, Charles University, Thomayer Hospital and University Hospital Kralovske Vinohrady, Prague, Czech Republic
| | - J Meilleroux
- Department of Pathology, IUC-T-Oncopole, Inserm U1037 CRCT, Université de Toulouse, Toulouse, France
| | - C Ortiz-Villalón
- Department of Pathology, Karolinska University Hospital, Stockholm, Sweden
| | - L Panico
- Unit of Pathology, Azienda Ospedaliera dei Colli, Monaldi-Cotugno-CTO, Naples, Italy
| | - A Panizo
- Department of Pathology, Complejo Hospitalario de Navarra, Pamplona, Spain
| | - M Papotti
- Department of Oncology, University of Torino, Torino, Italy
| | - P Pauwels
- Centre for Oncological Research (CORE), University of Antwerp, Antwerp, Belgium
| | - G Pelosi
- Department of Oncology and Hemato-Oncology, University of Milan, Milan, and IRCCS MultiMedica, Milan, Italy
| | - F Penault-Llorca
- Department of Pathology and Molecular Pathology, Centre Jean Perrin, Clermont-Ferrand, France
| | - O Pop
- Department of Pathology, University of Oradea, Oradea, Romania
| | - N Poté
- Department of Pathology, Bichat Hospital, AP-HP, Inserm UMR 1152, Université de Paris, Paris, France
| | - S R Y Cajal
- Department of Pathology, Vall d'Hebron University Hospital, Barcelona, Spain
| | - J-C Sabourin
- Department of Pathology, Inserm 1245, Rouen University Hospital Normandy University, Rouen, France
| | - I Salmon
- Department of Pathology, Erasme Hospital, Université Libre de Bruxelles, Brussels, Belgium
| | - M Sajin
- Department of Pathology, Emergency University Hospital, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania
| | - S Savic-Prince
- Institute of Pathology, Institute of Medical Genetics and Pathology, University Hospital Basel, Basel, Switzerland
| | - H-U Schildhaus
- Institute of Pathology, University Hospital Essen, Essen, Germany
| | - P Schirmacher
- Institute of Pathology, University Hospital Heidelberg, Heidelberg, and German Center for Lung Research (DZL), Germany
| | - I Serre
- Department of Biopathology, Gui de Chauliac Hospital, Montpellier University Hospital, Montpellier, France
| | - E Shaw
- Department of Cellular Pathology, University Hospital Southampton NHS Foundation Trust, Southampton, UK
| | - D Sizaret
- Department of Pathology, University Hospital of Tours, Tours, France
| | - A Stenzinger
- Institute of Pathology, University Hospital Heidelberg, Heidelberg, and German Center for Lung Research (DZL), Germany
| | - J Stojsic
- Department of Thoracic Pathology, Service of Pathology, University Clinical Centre of Serbia, Belgrade, Serbia
| | - E Thunnissen
- Department of Pathology, Amsterdam University Medical Centres, Location VUmc, Amsterdam, The Netherlands
| | - W Timens
- Department of Pathology and Medical Biology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
| | - G Troncone
- Department of Public Health, University of Naples Frederico II, Naples, Italy
| | - C Werlein
- Institute of Pathology, German Center for Lung Research, Biomedical Research in Endstage and Obstructive Lung Disease Hannover, Hannover Medical School, Hannover, Germany
| | - H Wolff
- Laboratory of Pathology, Finnish Institute of Occupational Health, Helsinki, Finland
| | - J-P Berthet
- Department of Thoracic Surgery, FHU OnoAge, Louis Pasteur Hospital, University Côte d'Azur, Nice, France
| | - J Benzaquen
- Department of Pneumology, FHU OncoAge, Louis Pasteur Hospital, IRCAN, Université Côte d'Azur, Nice, France
| | - C-H Marquette
- Department of Pneumology, FHU OncoAge, Louis Pasteur Hospital, IRCAN, Université Côte d'Azur, Nice, France
| | - V Hofman
- Laboratory of Clinical and Experimental Pathology, FHU OncoAge, BB-0033-00025, Louis Pasteur Hospital, IRCAN, Université Côte d'Azur, Nice, France
| | - F Calabrese
- Department of Cardiac, Thoracic, Vascular Sciences and Public Health, Pathological Anatomy Section, University of Padova Medical School, Padova, Italy
| |
Collapse
|
14
|
Oprean CM, Negru SM, Popovici DI, Saftescu S, Han RA, Dragomir GM, Hoinoiu T, Dema A. Postmenopausal Breast Cancer in Women, Clinical and Epidemiological Factors Related to the Molecular Subtype: A Retrospective Cohort Study in a Single Institution for 13 Years. Follow-Up Data. Int J Environ Res Public Health 2020; 17:ijerph17238722. [PMID: 33255341 PMCID: PMC7727650 DOI: 10.3390/ijerph17238722] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 10/13/2020] [Revised: 11/12/2020] [Accepted: 11/19/2020] [Indexed: 01/04/2023]
Abstract
This study focused on the characteristics of postmenopausal breast cancer in the population of southeastern Europe. This retrospective study explored the clinical, epidemiological, and molecular characteristics of women with postmenopausal breast cancer. MATERIAL AND METHODS A retrospective cohort study was performed on 721 postmenopausal breast cancer patients selected from the database of our institution. The data collected consisted of age, living environment, location of the breast tumor, stage of the disease, and molecular sub-type. Patient characteristics were collected based on a systematic chart audit from medical records. The data were analyzed using SPSS 20.0 and Pearson analysis. RESULTS The most frequent age range for breast cancer diagnosis was 51 to 70 years old. Most of the patients (80.7%) came from an urban environment. The vast majority of patients were initially diagnosed in stage II (40.3%) and III (30.3%). The most frequent molecular sub-types were luminal B (39%) and luminal A (35.4%). Almost half of the breast tumors were located in the upper outer quadrant (48.8%). CONCLUSIONS The results of this study describe the profile of patients in southeastern Europe within our institution diagnosed with postmenopausal breast cancer. In our study, patients were first diagnosed with more advanced stages of breast cancer compared with other European countries.
Collapse
Affiliation(s)
- Cristina Marinela Oprean
- Discipline of Morpho-pathology, “Victor Babeş” University of Medicine and Pharmacy, Eftimie Murgu Sq. No.2, 300041 Timişoara, Romania; (C.M.O.); (A.D.)
- Department of Oncology—ONCOMED Outpatient Unit, Ciprian Porumbescu Street, No. 59, 300239 Timisoara, Romania; (S.M.N.); (D.I.P.); (S.S.)
- Department of Oncology—ONCOHELP Hospital Timisoara, Ciprian Porumbescu Street, No. 59, 300239 Timisoara, Romania;
| | - Serban Mircea Negru
- Department of Oncology—ONCOMED Outpatient Unit, Ciprian Porumbescu Street, No. 59, 300239 Timisoara, Romania; (S.M.N.); (D.I.P.); (S.S.)
- Department of Oncology—ONCOHELP Hospital Timisoara, Ciprian Porumbescu Street, No. 59, 300239 Timisoara, Romania;
- Discipline of Oncology, “Victor Babeş” University of Medicine and Pharmacy, Eftimie Murgu Sq. No.2, 300041 Timişoara, Romania
| | - Dorel Ionel Popovici
- Department of Oncology—ONCOMED Outpatient Unit, Ciprian Porumbescu Street, No. 59, 300239 Timisoara, Romania; (S.M.N.); (D.I.P.); (S.S.)
- Department of Oncology—ONCOHELP Hospital Timisoara, Ciprian Porumbescu Street, No. 59, 300239 Timisoara, Romania;
- Discipline of Oncology, “Victor Babeş” University of Medicine and Pharmacy, Eftimie Murgu Sq. No.2, 300041 Timişoara, Romania
| | - Sorin Saftescu
- Department of Oncology—ONCOMED Outpatient Unit, Ciprian Porumbescu Street, No. 59, 300239 Timisoara, Romania; (S.M.N.); (D.I.P.); (S.S.)
- Department of Oncology—ONCOHELP Hospital Timisoara, Ciprian Porumbescu Street, No. 59, 300239 Timisoara, Romania;
- Discipline of Oncology, “Victor Babeş” University of Medicine and Pharmacy, Eftimie Murgu Sq. No.2, 300041 Timişoara, Romania
| | - Robert-Alexandru Han
- Department of Oncology—ONCOHELP Hospital Timisoara, Ciprian Porumbescu Street, No. 59, 300239 Timisoara, Romania;
| | - Gabriel-Mugurel Dragomir
- Department of Teaching Training—POLYTEHNICAL, University of Timisoara, 300223 Timisoara, Romania;
| | - Teodora Hoinoiu
- Department of Clinical Practical Skills, “Victor Babeş” University of Medicine and Pharmacy, Eftimie Murgu Sq. Nr.2, 300041 Timişoara, Romania
- Correspondence: ; Tel./Fax: +40-256-216510
| | - Alis Dema
- Discipline of Morpho-pathology, “Victor Babeş” University of Medicine and Pharmacy, Eftimie Murgu Sq. No.2, 300041 Timişoara, Romania; (C.M.O.); (A.D.)
| |
Collapse
|
15
|
Mihai IM, Olteanu GE, Herman D, Anderco D, Iacob M, Nataras B, Cumpanas AA, Bardan R, Dema A. Analysis of Tumor Depth Invasion With Anti-Smoothelin Antibody in Equivocal Transurethral Resection of Urinary Bladder Tumor Surgical Specimens. Int J Surg Pathol 2020; 29:54-63. [PMID: 33090031 DOI: 10.1177/1066896920967762] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Abstract
OBJECTIVE To examine the expression and value of the smoothelin marker in control cases, to standardize the working method, and to analyze its application in pathologic staging process of problematic transurethral resection of bladder tumor (TURBT) cases. MATERIAL AND METHODS Immunohistochemical (IHC) staining was performed on tumor-free bladder wall sections, tumor-free large bowel sections, TURBTs with unequivocal tumor stage, and TURBTs with equivocal stage. The IHC staining of muscularis mucosa (MM), muscularis propria (MP), and blood vessels was evaluated semiquantitatively. RESULTS Smoothelin IHC staining pattern ranged from negative (30% to 67% cases) to 2+ (0% to 15% cases) in MM and from 1+ (10% to 50% cases) to 3+ (9% to 48% cases) in MP. When compared on the same slide, the smoothelin expression of MP showed a stronger staining intensity than the one of the MM in all the analyzed cases. Blood vessel muscle cells stained in a constant intensity as the MM (r = 0.9808; r = 0.9604). Smoothelin determined restaging of 33% of the problematic TURBT cases. CONCLUSION Smoothelin is an IHC marker that shows differential staining between coexistent MM and MP; however, variations in staining intensity and pattern may occur, aspects that can be influenced by different technique variables. We recommend using this marker as a diagnostic tool in problematic TURBT cases only when there is sufficient experience in control cases with this antibody.
Collapse
Affiliation(s)
- Ioana Maria Mihai
- Department of Microscopic Morphology - Pathology, "Victor Babeș" University of Medicine and Pharmacy, Timisoara, Romania
| | - Gheorghe-Emilian Olteanu
- Department of Microscopic Morphology - Pathology, "Victor Babeș" University of Medicine and Pharmacy, Timisoara, Romania
- Centre for Gene and Cellular Therapies in Cancer-Oncogen, Timisoara, Romania
| | - Diana Herman
- Emergency County Hospital "Pius Brînzeu," Timisoara, Romania
| | - Denisa Anderco
- Emergency County Hospital "Pius Brînzeu," Timisoara, Romania
| | - Mihaela Iacob
- Emergency County Hospital "Pius Brînzeu," Timisoara, Romania
| | - Bianca Nataras
- Emergency County Hospital "Pius Brînzeu," Timisoara, Romania
| | - Alin Adrian Cumpanas
- Emergency County Hospital "Pius Brînzeu," Timisoara, Romania
- Department of Urology - "Victor Babeș" University of Medicine and Pharmacy, Timisoara, Romania
| | - Razvan Bardan
- Emergency County Hospital "Pius Brînzeu," Timisoara, Romania
- Department of Urology - "Victor Babeș" University of Medicine and Pharmacy, Timisoara, Romania
| | - Alis Dema
- Department of Microscopic Morphology - Pathology, "Victor Babeș" University of Medicine and Pharmacy, Timisoara, Romania
- Emergency County Hospital "Pius Brînzeu," Timisoara, Romania
| |
Collapse
|
16
|
Scholl S, Popovic M, Rochefordiere ADL, Girard E, Dureau S, Mandic A, Koprivsek K, Samet N, Craina M, Margan M, Samuels S, Zijlmans H, Kenter G, Hillemanns P, Dema S, Dema A, Malenkovic G, Djuran B, Floquet A, Garbay D, Guyon F, Colombo PE, Fabbro M, Kerr C, Ngo C, Lecuru F, Del Campo ER, Coutant C, Marchal F, Mesgouez-Nebout N, Fourchotte V, Feron JG, Morice P, Deutsch E, Wimberger P, Classe JM, Gleeson N, Leyen HVD, Minsat M, Dubot C, Gestraud P, Kereszt A, Nagy I, Balint B, Berns E, Jordanova E, de Saint-Jorre N, Savignoni A, Servant N, Hupe P, de Koning L, Fumoleau P, Rouzier R, Kamal M. Corrigendum to 'clinical and genetic landscape of treatment naive cervical cancer: Alterations in PIK3CA and in epigenetic modulators associated with sub-optimal outcome'. EBioMedicine 2020; 57:102875. [PMID: 32650273 PMCID: PMC7341345 DOI: 10.1016/j.ebiom.2020.102875] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/02/2022] Open
Affiliation(s)
- Suzy Scholl
- Institut Curie, PSL Research University, Department of Drug Development and Innovation, France.
| | - Marina Popovic
- Gynecologic Oncology Department Clinic for Operative Oncology, Institute of Oncology of Vojvodina, Serbia
| | | | - Elodie Girard
- Institut Curie, PSL Research University, Department of Drug Development and Innovation, France
| | - Sylvain Dureau
- Institut Curie, PSL Research University, Department of Drug Development and Innovation, France
| | - Aljosa Mandic
- Faculty of Medicine Novi Sad, University of Novi Sad, Serbia
| | - Katarina Koprivsek
- Gynecologic Oncology Department Clinic for Operative Oncology, Institute of Oncology of Vojvodina, Serbia; Faculty of Medicine Novi Sad, University of Novi Sad, Serbia
| | - Nina Samet
- Publica Institutul Oncologic, Republic of Moldova
| | - Marius Craina
- University of Medicine and Pharmacy "Victor Babeș", Romania
| | - Madalin Margan
- University of Medicine and Pharmacy "Victor Babeș", Romania
| | - Sanne Samuels
- Center for Gynaecologic Oncology Amsterdam, Amsterdam UMC and The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands
| | - Henry Zijlmans
- Center for Gynaecologic Oncology Amsterdam, Amsterdam UMC and The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands
| | - Gemma Kenter
- Center for Gynaecologic Oncology Amsterdam, Amsterdam UMC and The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands
| | | | - Sorin Dema
- University of Medicine and Pharmacy "Victor Babeș", Romania
| | - Alis Dema
- University of Medicine and Pharmacy "Victor Babeș", Romania
| | | | - Branislav Djuran
- Gynecologic Oncology Department Clinic for Operative Oncology, Institute of Oncology of Vojvodina, Serbia
| | - Anne Floquet
- Chirurgie onco-gynécologique and Oncology, Institut Bergonié, Centre Régional de Lutte contre le Cancer Bordeaux-Aquitaine, France
| | - Delphine Garbay
- Chirurgie onco-gynécologique and Oncology, Institut Bergonié, Centre Régional de Lutte contre le Cancer Bordeaux-Aquitaine, France
| | - Frédéric Guyon
- Chirurgie onco-gynécologique and Oncology, Institut Bergonié, Centre Régional de Lutte contre le Cancer Bordeaux-Aquitaine, France
| | | | | | | | - Charlotte Ngo
- Service de chirurgie cancérologique gynécologique et du sein, Hôpital Européen Georges Pompidou, APHP et faculté de médecine, Université Paris Descartes, France
| | - Fabrice Lecuru
- Service de chirurgie cancérologique gynécologique et du sein, Hôpital Européen Georges Pompidou, APHP et faculté de médecine, Université Paris Descartes, France
| | - Eleonor Rivin Del Campo
- Department of Radiation Oncology, Tenon University Hospital, Hôpitaux Universitaires Est Parisien, Sorbonne University Medical Faculty, Paris, France
| | | | - Frédéric Marchal
- Département de chirurgie, CRAN, UMR 7039, Université de Lorraine, CNRS, Institut de Cancérologie de Lorraine, 6 avenue de Bourgogne - CS 30519 54519, Vandoeuvre-les-Nancy Cedex, France
| | - Nathalie Mesgouez-Nebout
- Institut de cancérologie de l'Ouest - site Paul Papin (ICO) 15, Rue André Boquel, 49055 Angers, France
| | - Virginie Fourchotte
- Institut Curie, PSL Research University, Department of Drug Development and Innovation, France
| | - Jean Guillaume Feron
- Institut Curie, PSL Research University, Department of Drug Development and Innovation, France
| | | | | | - Pauline Wimberger
- Department of Gynecology and Obstetrics, Universitätsklinikum Carl Gustav Carus; an der Technischen Universität Dresden, Fetscherstraße 74, 01307 Dresden, Germany
| | | | | | | | - Mathieu Minsat
- Institut Curie, PSL Research University, Department of Drug Development and Innovation, France
| | - Coraline Dubot
- Institut Curie, PSL Research University, Department of Drug Development and Innovation, France
| | - Pierre Gestraud
- Institut Curie, PSL Research University, Department of Drug Development and Innovation, France
| | - Attila Kereszt
- SeqOmics Biotechnology Ltd, Vallalkozok utja 7, Morahalom, Hungary
| | - Istvan Nagy
- SeqOmics Biotechnology Ltd, Vallalkozok utja 7, Morahalom, Hungary
| | - Balazs Balint
- SeqOmics Biotechnology Ltd, Vallalkozok utja 7, Morahalom, Hungary
| | | | - Ekaterina Jordanova
- Center for Gynaecologic Oncology Amsterdam, Amsterdam UMC and The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands
| | | | - Alexia Savignoni
- Institut Curie, PSL Research University, Department of Drug Development and Innovation, France
| | - Nicolas Servant
- Institut Curie, PSL Research University, Department of Drug Development and Innovation, France
| | - Philippe Hupe
- Institut Curie, PSL Research University, Department of Drug Development and Innovation, France
| | - Leanne de Koning
- Institut Curie, PSL Research University, Department of Drug Development and Innovation, France
| | - Pierre Fumoleau
- Institut Curie, PSL Research University, Department of Drug Development and Innovation, France
| | - Roman Rouzier
- Institut Curie, PSL Research University, Department of Drug Development and Innovation, France
| | - Maud Kamal
- Institut Curie, PSL Research University, Department of Drug Development and Innovation, France
| |
Collapse
|
17
|
Boros M, Resetkova E, Molnar C, Podoleanu C, Dema A, Olinca M, Alvarado-Cabrero I, Buiga R, Stolnicu S. Analysis of Clinical-Pathological Data with Impact on Overall Survival in Male Breast Carcinoma: An International Multi-Institutional Study of 217 Cases. Chirurgia (Bucur) 2020; 115:323-333. [DOI: 10.21614/chirurgia.115.3.323] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 06/01/2020] [Indexed: 11/23/2022]
|
18
|
Mihai I, Taban S, Cumpanas A, Olteanu EG, Iacob M, Dema A. Clear cell urothelial carcinoma of the urinary bladder - a rare pathological entity. A case report and a systematic review of the literature. Bosn J Basic Med Sci 2019; 19:400-403. [PMID: 30957722 DOI: 10.17305/bjbms.2019.4182] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/06/2019] [Accepted: 03/23/2019] [Indexed: 01/04/2023] Open
Abstract
The most common histological type of urinary bladder cancer is urothelial carcinoma (UC). In contrast, the clear cell variant of urothelial carcinoma (CCUC) is quite a rare neoplasm. In this study, we report a case of an 81-year-old male, presenting with gross hematuria and acute urinary retention, which was subsequently diagnosed with CCUC at our pathology department. Furthermore, we provide a short systematic review of the literature (PubMed, Scopus, and Science Citation Index) for this rare histopathological entity and a brief discussion about its morphological and immunohistochemical (IHC) characteristics.
Collapse
Affiliation(s)
- Ioana Mihai
- Department of Morphopathology, The Victor Babes University of Medicine and Pharmacy of Timisoara, Timisoara, Romania.
| | | | | | | | | | | |
Collapse
|
19
|
Vermesan D, Prejbeanu R, Haragus H, Dema A, Oprea MD, Andrei D, Poenaru DV, Niculescu M. Case series of patients with pathological dyaphiseal fractures from metastatic bone disease. Int Orthop 2017; 41:2199-2203. [PMID: 28770293 DOI: 10.1007/s00264-017-3582-3] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/18/2017] [Accepted: 07/06/2017] [Indexed: 12/17/2022]
Abstract
INTRODUCTION Fractures on pathologic bone have major impact on life quality. The appropriate treatment is not standardized, but the current literature delineates that surgery must provide adequate stabilization for the life expectancy. We aimed to review the epidemiology, treatment outcomes and survival in our department. MATERIAL AND METHODS The electronic database from a major referral centre was searched for patients treated for tumours and fractures by the corresponding ICM-10 codes over five years. Eighty-nine patients were identified. Eleven females and nine males, with an average age of 64 years underwent 23 operations during the selected timeframe. Six fractures were subtrochanteric, five at the femoral neck and five at the femoral diaphysis. Seventeen cases were metastatic carcinomas, out of which five mammary, three pulmonary and seven carcinomas of undetermined origin without immunohistochemistry. RESULTS Fourteen types of surgical intervention were osteosynthesis with intramedullary nails and six were partial hip replacements of which one had proximal femur resection and revision stem hemiarthroplasty. Four patients had single metastatic lesions which underwent resection and defect filling using PMMA cement (polymethylmethacrylate). The follow-up period ranged between two and seven years or until death. Only five patients (25%) were alive at the last follow-up. Local recurrence appeared in one patient. There was one immediate post-operative complication (dehiscent wound) and one implant failure after five years and was replaced with a larger diameter (exchange nailing). CONCLUSION Both hip arthroplasty and femoral nailing are safe and routine procedures that are performed with relatively technical ease and low surgical stress and few peri-operative complications for the patient. They allow for immediate mobilization and weight-bearing with moderate and rapidly decreasing pain and discomfort.
Collapse
Affiliation(s)
- Dinu Vermesan
- Department of Orthoapedics and Trauma, University of Medicine and Pharmacy 'Victor Babes' Timisoara, Eftimie Murgu Square No. 2, 300041, Timisoara Timis, Romania
| | - Radu Prejbeanu
- Department of Orthoapedics and Trauma, University of Medicine and Pharmacy 'Victor Babes' Timisoara, Eftimie Murgu Square No. 2, 300041, Timisoara Timis, Romania
| | - Horia Haragus
- Department of Orthoapedics and Trauma, University of Medicine and Pharmacy 'Victor Babes' Timisoara, Eftimie Murgu Square No. 2, 300041, Timisoara Timis, Romania
| | - Alis Dema
- Department of Anatomopathology, University of Medicine and Pharmacy 'Victor Babes' Timisoara, Eftimie Murgu Square No. 2, 300041, Timisoara Timis, Romania
| | - Manuel D Oprea
- Department of Orthoapedics and Trauma, University of Medicine and Pharmacy 'Victor Babes' Timisoara, Eftimie Murgu Square No. 2, 300041, Timisoara Timis, Romania
| | - Diana Andrei
- Rehabilitation and Physical Medicine Department, University of Medicine and Pharmacy 'Victor Babes' Timisoara, Eftimie Murgu Square No. 2, 300041, Timisoara Timis, Romania
| | - Dan V Poenaru
- Department of Orthoapedics and Trauma, University of Medicine and Pharmacy 'Victor Babes' Timisoara, Eftimie Murgu Square No. 2, 300041, Timisoara Timis, Romania.
| | - Marius Niculescu
- Department of Orthopaedics and Trauma, Faculty of Medicine, University 'Titu Maiorescu' Bucharest, 22 Dâmbovnicului, 040441, Sector 4, Bucharest, Romania
| |
Collapse
|
20
|
Golu I, Vlad MM, Dema A, Moleriu LC, Tudor A, Iacob M, Popa O, Cornianu M. The absence of CD56 expression can differentiate papillary thyroid carcinoma from other thyroid lesions. INDIAN J PATHOL MICR 2017. [PMID: 28631628 DOI: 10.4103/0377-4929.208378] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022] Open
Abstract
CONTEXT The neural cell adhesion molecule CD56 is an antigen important for the differentiation of the follicular epithelium. Recent studies have reported low or absent expression of CD56 in papillary thyroid carcinoma (PTC) and its presence in normal thyroid tissue, benign thyroid lesions, and most follicular non-PTC tumors. AIM We wish to estimate the value of CD56 in the differentiation of PTC (including follicular variant-PTC [FV-PTC]) from other nontumoral lesions and follicular thyroid neoplasias. SETTINGS AND DESIGN This was a retrospective, case-control study. SUBJECTS AND METHODS We analyzed the expression of CD56 in normal thyroid follicular tissue, 15 nonneoplastic thyroid lesions (nodular hyperplasia, Graves' disease, and chronic lymphocytic thyroiditis/Hashimoto), and 38 thyroid follicular cell neoplasms (25 cases of PTC). The immunohistochemical reactions were performed on sections stained with anti-CD56 antibody. STATISTICAL ANALYSIS USED We used the Chi-square test, values of P< 0.05 being considered statistically significant. Risk analysis was applied on these studied groups, by calculating the odds ratio (OR) value. RESULTS Our results indicated that CD56 immunoexpression had differentiated PTC from benign nonneoplastic lesions (P = 0.002), as well as from follicular neoplasias (P = 0.046). There were no significant differences regarding CD56 expression between FV-PTC and classical PTC (P = 0.436). The immunoexpression of CD56 has differentiated PTC from other thyroid non-PTC lesions (P < 0.001), with 26.4 OR value. CONCLUSIONS CD56 has been proved to be a useful marker in the diagnosis of PTC, including FV-PTC. Its absence can help differentiate FV-PTC from other thyroid nodules with follicular patterns.
Collapse
Affiliation(s)
- Ioana Golu
- Department of Endocrinology, "Victor Babes" University of Medicine and Pharmacy, Timisoara, Romania
| | - Mihaela Maria Vlad
- Department of Endocrinology, "Victor Babes" University of Medicine and Pharmacy, Timisoara, Romania
| | - Alis Dema
- Department of Pathology, "Victor Babes" University of Medicine and Pharmacy, Timisoara, Romania
| | - Lavinia Cristina Moleriu
- Department of Medical Informatics, "Victor Babes" University of Medicine and Pharmacy, Timisoara, Romania
| | - Anca Tudor
- Department of Medical Informatics, "Victor Babes" University of Medicine and Pharmacy, Timisoara, Romania
| | - Mihaela Iacob
- Department of Pathology, "Pius Brinzeu" County Emergency Hospital, Timisoara, Romania
| | - Oana Popa
- Department of Endocrinology, "Pius Brinzeu" County Emergency Hospital, Timisoara, Romania
| | - Marioara Cornianu
- Department of Pathology, "Victor Babes" University of Medicine and Pharmacy, Timisoara, Romania
| |
Collapse
|
21
|
Cornea R, Taban S, Suciu C, Lazureanu C, Dema A. Intestinal heterotopic pancreas involved by simultaneous PanIN-2 lesion and endocrine microadenoma: a unique case. J Gastrointestin Liver Dis 2017; 26:199-202. [PMID: 28617892 DOI: 10.15403/jgld.2014.1121.262.pan] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/01/2022]
Abstract
We hereby present the case of a 58-year-old male who underwent a total gastrectomy for gastric neoplasm. During the surgery, a tumor mass in the jejunum was identified, considered as metastasis, and resected. The histopathological examination of the jejunal lesion showed ectopic pancreas. In this area, two pathological distinct lesions were identified, one histologically compatible with pancreatic intraepithelial neoplasia (PanIN) type 2 lesion and the other with morphologic criteria for endocrine microadenoma. To our knowledge, this is the first case that evidences the presence of a concomitant premalignant exocrine lesion and benign endocrine lesion in a heterotopic pancreas.
Collapse
Affiliation(s)
- Remus Cornea
- Pathology Department, Victor Babes University of Medicine and Pharmacy, Timisoara, Romania.
| | - Sorina Taban
- Pathology Department, Victor Babes University of Medicine and Pharmacy;Pathology Department, Pius Brinzeu County Clinical Hospital, Timisoara, Romania
| | - Cristian Suciu
- Pathology Department, Pius Brinzeu County Clinical Hospital;Histology Department, Victor Babes University of Medicine and Pharmacy, Timisoara, Romania
| | - Codruta Lazureanu
- Pathology Department, Victor Babes University of Medicine and Pharmacy;Pathology Department, Pius Brinzeu County Clinical Hospital, Timisoara, Romania
| | - Alis Dema
- Pathology Department, Victor Babes University of Medicine and Pharmacy;Pathology Department, Pius Brinzeu County Clinical Hospital, Timisoara, Romania
| |
Collapse
|
22
|
Oprean C, Borcan F, Pavel I, Dema A, Danciu C, Soica C, Dehelean C, Nicu A, Ardelean A, Cristea M, Ivan A, Tatu C, Bojin F. In Vivo Biological Evaluation of Polyurethane Nanostructures with Ursolic and Oleanolic Acids on Chemically-induced Skin Carcinogenesis. In Vivo 2016; 30:633-8. [PMID: 27566083] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/23/2016] [Accepted: 05/31/2016] [Indexed: 06/06/2023]
Abstract
BACKGROUND/AIM Oleanolic and ursolic acids (OA and UA) are two pentacyclic triterpenes, ubiquitously spread in plants, previously known for their chemopreventive capacity on different types of cancer. The major pharmacological disadvantage of these phytocompounds is their poor water solubility, which often limits their applicability. MATERIALS AND METHODS Using the interfacial polycondensation combined with spontaneous emulsification technique, polyurethane nanostructures (PU) were synthetized in order to improve this problem. In order to test the in vivo chemopreventive potential of the two pure compounds, as well as the encapsulated compounds in PU used as drug carriers, a chemically-induced skin carcinogenesis model was constructed. RESULTS UA and OA have a moderate chemopreventive activity against tumors induced by 7,12-dimethylbenzantracene (DMBA) and 12-O-tetradecanoilphorbol-13-acetate (TPA) application. Incorporation of active agents in PU did not lead to increased chemopreventive effect. CONCLUSION PU is not a suitable formulation of UA and OA.
Collapse
Affiliation(s)
- Camelia Oprean
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Victor Babes University of Medicine and Pharmacy, Timisoara, Romania
| | - Florin Borcan
- Department of Analitical Chemistry, Faculty of Pharmacy, Victor Babes University of Medicine and Pharmacy, Timisoara, Romania
| | - Ioana Pavel
- Department of Pharmacognosy, Faculty of Pharmacy, Victor Babes University of Medicine and Pharmacy, Timisoara, Romania
| | - Alis Dema
- Department of Morphopathology, Faculty of Medicine, Victor Babes University of Medicine and Pharmacy, Timisoara, Romania
| | - Corina Danciu
- Department of Pharmacognosy, Faculty of Pharmacy, Victor Babes University of Medicine and Pharmacy, Timisoara, Romania
| | - Codruta Soica
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Victor Babes University of Medicine and Pharmacy, Timisoara, Romania
| | - Cristina Dehelean
- Department of Toxicology, Faculty of Pharmacy, Victor Babes University of Medicine and Pharmacy, Timisoara, Romania
| | - Andreea Nicu
- Student at Faculty of Pharmacy, Victor Babeş University of Medicine and Pharmacy, Timisoara, Romania
| | - Anamaria Ardelean
- Student at Faculty of Pharmacy, Victor Babeş University of Medicine and Pharmacy, Timisoara, Romania
| | - Mirabela Cristea
- "Pius Brinzeu" Timişoara County Emergency Clinical Hospital, Timisoara, Romania
| | - Alexandra Ivan
- Department of Functional Sciences, Faculty of Medicine, Victor Babes University of Medicine and Pharmacy, Timisoara, Romania
| | - Calin Tatu
- Department of Functional Sciences, Faculty of Medicine, Victor Babes University of Medicine and Pharmacy, Timisoara, Romania
| | - Florina Bojin
- Department of Functional Sciences, Faculty of Medicine, Victor Babes University of Medicine and Pharmacy, Timisoara, Romania
| |
Collapse
|
23
|
Mihala A, Alexa AA, Samoilă C, Dema A, Vizitiu AC, Anghel A, Tămaş L, Marian CV, Sîrbu IO. A pilot study on the expression of microRNAs resident on chromosome 21 in laser microdissected FFPE prostate adenocarcinoma samples. Rom J Morphol Embryol 2015; 56:1063-1068. [PMID: 26662140] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/05/2023]
Abstract
The tremendous research effort of the last decades added a new, epigenetic layer of complexity to the already complex image of prostate cancer pathogenesis. Here we use quantitative real-time polymerase chain reaction (qRT-PCR) to investigate the expression of the microRNAs resident on chromosome 21 (miR-ch21) in laser capture microdissected (LCM) tissues from formalin-fixed paraffin-embedded (FFPE) archived, prostate adenocarcinoma samples. We show a strong, specific down-regulation of miR-ch21 in tumoral epithelia and stromae as compared to normal counterparts, results at odd with the current paradigm on the involvement of these microRNAs in prostate oncogenesis. By comparing this result with the expression of two well-known pluripotency associated microRNA, hsa-miR-372 and miR-373, we suggest that miR-ch21 down-regulation might be the result of specific silencing of miR genes mapped to chromosome 21. Further studies, of larger sample size are needed to confirm our preliminary data.
Collapse
Affiliation(s)
- Adrian Mihala
- Department of Biochemistry and Pharmacology, "Victor Babes" University of Medicine and Pharmacy, Timisoara, Romania; ,
| | | | | | | | | | | | | | | | | |
Collapse
|
24
|
Deleanu B, Prejbeanu R, Crisan D, Vermesan D, Predescu V, Iacob M, Dema A. Subtrochanteric Fracture as First Sign of Metastatic Breast Cancer: Case Presentation. J Med Cases 2015. [DOI: 10.14740/jmc2216w] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022] Open
|
25
|
Bob F, Gluhovschi G, Herman D, Petrica L, Bozdog G, Gluhovschi C, Velciov S, Gadalean F, Timar R, Potencz E, Dema A, Schiller A. Immunohistochemical study of tubular epithelial cells and vascular endothelial cells in glomerulonephritis. Ren Fail 2014; 36:1208-14. [DOI: 10.3109/0886022x.2014.929525] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
26
|
Bardan R, Dumache R, Dema A, Cumpanas A, Bucuras V. The role of prostatic inflammation biomarkers in the diagnosis of prostate diseases. Clin Biochem 2014; 47:909-15. [PMID: 24560954 DOI: 10.1016/j.clinbiochem.2014.02.008] [Citation(s) in RCA: 25] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/21/2013] [Revised: 02/04/2014] [Accepted: 02/10/2014] [Indexed: 11/27/2022]
Abstract
Benign prostatic hyperplasia (BPH) and prostate cancer (PCa) are chronic conditions, which are hormone-dependent and epidemiologically associated with prostate inflammation. As a large number of studies have demonstrated, the stimulation of T-cells at the level of prostatic chronic inflammatory infiltrates is followed by stromal and epithelial cell proliferation. The aim of this review is to present the actual level of knowledge in the field of prostatic immune response and chronic inflammation, and to analyze the relationships between chronic inflammation and BPH/PCa. The most studied prostatic inflammation biomarkers detected in biological fluids are also presented, together with their potential roles in the diagnosis and prognosis of prostatic disease.
Collapse
Affiliation(s)
- Razvan Bardan
- Department of Urology, "Victor Babes" University of Medicine and Pharmacy, Timisoara, Romania.
| | - Raluca Dumache
- Department of Biochemistry, "Victor Babes" University of Medicine and Pharmacy, Timisoara, Romania
| | - Alis Dema
- Department of Pathology, "Victor Babes" University of Medicine and Pharmacy, Timisoara, Romania
| | - Alin Cumpanas
- Department of Urology, "Victor Babes" University of Medicine and Pharmacy, Timisoara, Romania
| | - Viorel Bucuras
- Department of Urology, "Victor Babes" University of Medicine and Pharmacy, Timisoara, Romania
| |
Collapse
|
27
|
Nodiţi G, Nica CC, Petrescu HP, Ivan C, Crăiniceanu ZP, Bratu T, Dema A. Pathological assessment of tumor biopsy specimen and surgical sentinel lymph node dissection in patients with melanoma. Rom J Morphol Embryol 2014; 55:915-918. [PMID: 25329120] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/04/2023]
Abstract
INTRODUCTION Actual trends of cutaneous malignant melanoma show a faster increase then other forms of cancer. Early detection and diagnosis, and accurate pathologic interpretation of the biopsy specimen is extremely important for the treatment and prognosis of clinically localized melanoma. The surgical approach to cutaneous melanoma patients with clinically uninvolved regional lymph nodes remains controversial. MATERIALS AND METHODS A retrospective study of melanoma cases was conducted in the "Casa Austria" Department of Plastic and Reconstructive Surgery, Emergency County Hospital, Timisoara, Romania. We have analyzed the medical records of 21 patients that underwent surgical treatment for different stages of melanoma in the period 2008-2012. For histopathological diagnosis of melanoma and the sentinel lymph node(s) status, tissular fragments were routinely processed. For the difficult cases, additional immunohistochemical investigation was done. RESULTS A positive family history was noted in two cases. The presence of different sizes and localization of pigmented nevi was found in 38% of the cases. Different types of melanoma like superficial spreading melanoma, nodular melanoma or lentigo malignant melanoma and acral lentiginous melanoma was described. The surgical treatment consisted in all cases in wide excision of the primary tumor and prophylactic dissection of sentinel lymph node after lymphoscintigraphy examination. A positive biopsy of the sentinel lymph node was noted in 4.9% of the cases. CONCLUSIONS The surgical treatment combining the wide excision of the primary tumor with respect to safe oncological limits with the prophylactic dissection of sentinel lymph node after lymphoscintigraphy examination had the confirmation done by the pathologic interpretation of the biopsy specimen showing that all the patients had a Breslow index more than 1.5 mm.
Collapse
Affiliation(s)
- Gheorghe Nodiţi
- Department of Orthopedics and Trauma, "Victor Babes" University of Medicine and Pharmacy, Timisoara, Romania;
| | | | | | | | | | | | | |
Collapse
|
28
|
Suciu C, Muresan A, Cornea R, Suciu O, Dema A, Raica M. Semi-automated evaluation of Ki-67 index in invasive ductal carcinoma of the breast. Oncol Lett 2013; 7:107-114. [PMID: 24348830 PMCID: PMC3861561 DOI: 10.3892/ol.2013.1654] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/08/2013] [Accepted: 10/08/2013] [Indexed: 12/19/2022] Open
Abstract
A significant factor that affects the value of the Ki-67 proliferation index (IK) is the interpretation and implementation approach. This method is based on visual or automated methods to count tumor nuclei labeled with Ki-67 antigen, and is prone to errors. Detection of Ki-67 is a useful tool in breast cancer and contributes to its molecular classification. The current study proposes a method for the quantification of Ki-67-positive tumor nuclei, which allows for the determination of the exact IK value that is required for tumor stratification based on the proliferation rate. The IK was assessed in 81 successive cases of diagnosed invasive ductal breast carcinoma using a semi-automated method that accurately identifies positive tumor cell nuclei. This method prevents the inclusion of other possible positive cells, including lymphoid, normal epithelia and hyperplastic. In small specimens with increased cell density, where the nucleus/cytoplasm ratio is markedly in favor of the nucleus and the distance between nuclei is small, the method allows precise quantification of the nuclei, even when the limits between nuclei are difficult to identify. In addition, images may be stored in a database, including the assessments, and easily accessed when required. We hypothesize that the semi-automated method for counting nuclei offers the most accurate method of assessing the IK and avoids counting errors that may occur through other methods.
Collapse
Affiliation(s)
- Cristian Suciu
- Department of Microscopic Morphology, 'Victor Babes' University of Medicine and Pharmacy, Timişoara, Timiş 300041, Romania ; Department of Pathology, Emergency County Hospital, Timişoara, Timiş 300736, Romania
| | - Anca Muresan
- Department of Microscopic Morphology, 'Victor Babes' University of Medicine and Pharmacy, Timişoara, Timiş 300041, Romania ; Department of Pathology, Emergency County Hospital, Timişoara, Timiş 300736, Romania
| | - Remus Cornea
- Department of Microscopic Morphology, 'Victor Babes' University of Medicine and Pharmacy, Timişoara, Timiş 300041, Romania
| | - Oana Suciu
- Department of Rehabilitation, 'Victor Babes' University of Medicine and Pharmacy Timişoara, Timişoara, Timiş 300041, Romania
| | - Alis Dema
- Department of Microscopic Morphology, 'Victor Babes' University of Medicine and Pharmacy, Timişoara, Timiş 300041, Romania ; Department of Pathology, Emergency County Hospital, Timişoara, Timiş 300736, Romania
| | - Marius Raica
- Department of Microscopic Morphology, 'Victor Babes' University of Medicine and Pharmacy, Timişoara, Timiş 300041, Romania
| |
Collapse
|
29
|
Botoca M, Cumpanas A, Dema A, Minciu R, Fahes M, Iacob C, Mokdad M, Bucuras V. MP-04.20 The Role of Secondary TUR in High Risk, Non-Muscle-Invasive Bladder Tumors. Urology 2011. [DOI: 10.1016/j.urology.2011.07.094] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/16/2022]
|
30
|
Olariu S, Farca I, Ciorogar G, Bloancă V, Dema A. [Intramural intestinal hematoma--a complication of the oral anticoagulant therapy]. Chirurgia (Bucur) 2011; 106:551-554. [PMID: 21991886] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/31/2023]
Abstract
AIM The presentation of a rare complication of oral anticoagulant treatment involving abdominal surgery. MATERIAL AND METHOD A 59 years old patient who received oral anticoagulant treatment with Warfarine for repeated episodes of thrombosis of the lower limbs, suddenly develops an occlusive abdominal simptoms, which did not submit under conservative treatment. Biologically the clotting times were modified and the abdominal CT showed lesions of the first jejunal loop. RESULTS During surgery an amount of blood was found in abdominal cavity and a large haematoma of the first jejunal loop which required resection. The postoperative evolution was simple with discharge in the 12th day, surgically cured. CONCLUSIONS 1. Intramural intestinal haematoma is a rare, but possible complication of the oral anticoagulant treatment. 2. Precise diagnosis is possible, avoiding unnecessary surgical intervention because the complication is treatable using conservative therapy. 3. Surgical intervention is required in case of a sudden onset, imprecise diagnosis and unfavorable evolution which could point associated intraabdominal lesions.
Collapse
Affiliation(s)
- S Olariu
- Clinica I Chirurgie, Spitalul Clinic Judeţean de Urgenţă, Universitatea Medicină si Farmacie "V. Babeş", Timişoara, România.
| | | | | | | | | |
Collapse
|
31
|
Dema A. Neuroendocrine Dedifferentiation of a Prostate Adenocarcinoma after Hormonal Treatment - A Case Study. Acta Endo (Buc) 2011. [DOI: 10.4183/aeb.2011.535] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
|
32
|
Loghin A, Preda O, Bacârea V, Moldovan C, Porav-Hodade D, Dema A, Berger N, Borda A. Predictive preoperatory variables of the prostate tumor volume. Rom J Morphol Embryol 2011; 52:363-368. [PMID: 21424075] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/30/2023]
Abstract
Prostate cancer (PCa) is the second most frequent malignant tumor in men worldwide and the most common form of cancer in men over 50-year-old. The adequate preoperative estimation of tumor volume in order to identify small tumors that lack a short-term aggressive behavior and do not necessitate a forthwith-radical prostatectomy (RP) is the subject of various recent studies and numerous debates. In this study, that included 128 cases, we attempted to evaluate some of the common preoperative variables (patient's age, total prostate volume determined on ultrasound examination, serum PSA, the number of positive biopsies and tumor size, the percentage of tumor length and the Gleason score) that could predict the tumor volume on the final RP. Based on these correlations, we develop a scoring system that combines only the Gleason score, the number of positive biopsies and the percentage of tumor length and that has been statistically proved to be correlated and predictive for the tumor volume. Our study brings additional and practical information about a true and effective prospective evaluation of the volume of the PCa.
Collapse
Affiliation(s)
- Andrada Loghin
- Department of Histology, University of Medicine and Pharmacy of Targu Mures, Romania.
| | | | | | | | | | | | | | | |
Collapse
|
33
|
Cornianu M, Stan V, Lazăr E, Dema A, Golu I, Tăban S, Vlad M, Faur A, Vărcuş F, Babău F. Evaluation of proliferation potential in thyroid normo-/hypofunctioning and hyperfunctioning nodules. Rom J Morphol Embryol 2011; 52:545-553. [PMID: 21655641] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/30/2023]
Abstract
INTRODUCTION Thyroid follicular adenomas (FA) and adenomatous thyroid nodules (AN) - lesions that are frequently found in areas with iodine deficiency, can be normo-/hypofunctioning (scintigraphically cold - SCN) or hyperfunctioning (scintigraphically hot - SHN) nodules. AIM Evaluation of proliferation potential in thyroid nodules on tissue samples obtained at surgery from euthyroid patients clinically diagnosed with SCN and from patients with thyroid hyperfunction and SHN. MATERIALS AND METHODS We investigated the proliferation activity estimated by assessing PCNA and Ki-67 proliferation markers in 20 SCN (eight FA and 12 AN) and 16 toxic nodules (six hyperfunctioning FA and 10 toxic multinodular goiters), on formalin-fixed and paraffin-embedded tissue samples, 4-5 μm thick; we used the immunohistochemical technique in LSAB system (DAB visualization) with anti-PCNA (PC10) and anti-Ki-67 (MIB-1) monoclonal antibodies. For each case, we calculated the proliferation index PI-PCNA and PI-Ki-67. The dates were statistically evaluated using the t-unpaired test. RESULTS We observed a higher PI-PCNA in thyroid nodules than in the normal surrounding thyroid tissue, with statistically significant values for FA (14.3% vs. 3.8%; p<0.029) and also for AN (8.36% vs. 1.24%; p<0.001). The mean PI-Ki-67 in nodules vs. surrounding thyroid tissue was 1.64% vs. 1.10% in FA (p<0.35) and 1.07% vs. 0.51% in AN (p>0.05). We also noted: (1) significantly higher PI-PCNA values (p < 0.01) in FA (14.03%) than in AN (8.36%), as compared to statistically insignificant values for Ki-67 (1.64% vs. 1.07%; p>0.05); (2) increased proliferation rate (p<0.01) in thyroid nodules with aspects of lymphocytic thyroiditis (LT) (PI-Ki-67 was 1.21%) as compared to nodules without LT (PI-Ki-67 was 0.12%); (3) a mean PI-PCNA of 8.5% and PI-Ki-67 of 4.61% in toxic thyroid nodules (TTN) vs. 3.01% and 1.5% in normal surrounding thyroid, respectively. CONCLUSIONS The clinical expression of SCN is the consequence of increased thyrocyte proliferation in the nodules; the increased proliferative potential of TTN thyrocytes is a common feature of nodules, independent of their histopathological characteristics.
Collapse
Affiliation(s)
- Marioara Cornianu
- Department of Pathology, Victor BabesUniversity of Medicine and Pharmacy, Timisoara, Romania.
| | | | | | | | | | | | | | | | | | | |
Collapse
|
34
|
Dema A, Tăban S, Lazăr E, Borda A, Lăzureanu C, Herman D, Mureşan A, Cornianu M, Anderco D, Loghin A. Pseudobenign prostate carcinomas: causes of false-negative biopsy results. Rom J Morphol Embryol 2011; 52:963-974. [PMID: 22119811] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/31/2023]
Abstract
Prostate carcinomas are continuously surprising the pathologists through their multitude of variants and histological subtypes, some of them being recently described and characterized. Among these are individualized: atrophic carcinoma, foamy gland, pseudohyperplastic, microcystic, certain subtypes of ductal adenocarcinoma and hormone-treated adenocarcinoma, which because of minimal architectural and/or cytological atypia are often under-diagnosed, especially in small tissue fragments. This paper presents the morphological criteria, including information provided by some immunohistochemical markers for positive and differential diagnosis of these variants/subtypes of prostate adenocarcinoma with which the pathologist should be familiar and avoid their confusion with a series of similar histological structures or benign/premalignant lesions.
Collapse
Affiliation(s)
- Alis Dema
- Department of Pathology, Victor Babeş University of Medicine and Pharmacy, Timisoara, Romania.
| | | | | | | | | | | | | | | | | | | |
Collapse
|
35
|
Herbeck R, Teodorescu Brînzeu D, Giubelan M, Lazăr E, Dema A, Ioniţă H. B-cell transcription factors Pax-5, Oct-2, BOB.1, Bcl-6, and MUM1 are useful markers for the diagnosis of nodular lymphocyte predominant Hodgkin lymphoma. Rom J Morphol Embryol 2011; 52:69-74. [PMID: 21424034] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/30/2023]
Abstract
In some instances, the overlap in morphologic features and antigen expression between nodular lymphocyte predominant Hodgkin lymphoma (NLPHL) and classical Hodgkin lymphoma (cHL) can cause confusion in the diagnosis. In these cases, the transcription factors (TFs) B-cell specific activator protein (BSAP)/Pax-5, octamer binding protein-2 (Oct-2), B-lymphocyte-specific co-activator BOB.1/OBF.1, Bcl-6 protein and multiple myeloma-1/interferon regulatory factor-4 (MUM1/IRF-4) may aid in clarifying the diagnosis. Twenty-two cases of NLPHL were studied for the immunohistochemical expression of Pax-5, Oct-2, BOB.1, Bcl-6 protein and MUM1/IRF-4. Our results sustain the usefulness of the selected set of TFs to diagnose and distinguish NLPHL from cHL since Pax-5, Oct-2, BOB.1 and Bcl-6 are consistently expressed by lymphocyte predominant (LP) cells and reported by others to be often unexpressed in Hodgkin and Reed-Sternberg cells. By contrast, MUM1/IRF-4 protein scored negative in the majority of LP cells, but is reported to be expressed in almost all cases of cHL. Thus, although the expression of transcription factors is very heterogeneous, their simultaneous implementation for positive and differential diagnosis may be useful.
Collapse
Affiliation(s)
- Rosemarie Herbeck
- Department of Pathology, Emergency County Hospital, Timisoara, Romania.
| | | | | | | | | | | |
Collapse
|
36
|
Olariu S, Ruhmann C, Bloancă V, Shekhda J, Străin M, Dema A. [Intestinal stromal tumors, rare cause of lower gastrointestinal bleeding. Case report]. Chirurgia (Bucur) 2010; 105:721-726. [PMID: 21141104] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/30/2023]
Abstract
Gastrointestinal stromal tumors represent a heterogeneous group of mesenchymal tumors that can develop throughout the gastrointestinal tract. We present the clinical case of a patient with such malignancies occurred in the proximal jejunum and clinically manifested by a severe digestive hemorrhage with hemorrhagic shock and severe posthemorrhagic anemia. Pre-operative diagnosis was possible only through the Entero-MRI. The evolution was favorable after surgical extirpation. It's being discussed particular aspects of this lesion's entity and post-operative optimal attitude in this case.
Collapse
Affiliation(s)
- S Olariu
- Clinica I Chirurgie, Spitalul Clinic Judeţean de Urgenţă Timişoara, U.M.F. "V. Babeş", Timişoara, Romania.
| | | | | | | | | | | |
Collapse
|
37
|
Dema A, Borda A, Lazăr E, Lăzureanu C, Tăban S, Anderco D, Cornianu M, Mureşan A, Herman D, Loghin A, Cornea R, Faur A. Prostate lesions with cribriform / pseudocribriform pattern. Rom J Morphol Embryol 2010; 51:413-425. [PMID: 20809015] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/29/2023]
Abstract
Prostate lesions with cribriform / pseudocribriform architecture range from normal histological structures to infiltrative carcinoma. In each group of lesions with cribriform architecture (benign, premalignant and malignant intraductal or infiltrating), there are situations in which histological classification of the lesion is difficult or impossible on routine stains. A more wide-scale application of the immunohistochemical investigation for clearing up the problematic prostate lesions led to the definition and reclassification of cribriform lesions in distinct categories and sometimes very different in terms of progression, prognosis and treatment. This paper proposes an overview of the prostate lesions with cribriform / pseudocribriform architecture, emphasizing the morpho-immunohistochemical criteria for positive and differential diagnosis.
Collapse
Affiliation(s)
- Alis Dema
- Department of Pathology, Victor Babes University of Medicine and Pharmacy, Timisoara, Romania.
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
38
|
Anderco D, Lazăr E, Tăban S, Miclea F, Dema A. Prostatic blue nevus. Rom J Morphol Embryol 2010; 51:555-557. [PMID: 20809037] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/29/2023]
Abstract
We report the case of a 69-year-old patient with no significant personal urological history. The clinical and ultrasound examination revealed a prostatic gland with increased volume and homogenous appearance. After transurethral resection, multiples gray-brown-blackish prostatic chips were obtained, which could be confused with a malignant melanoma. The histological routine examination in conjunction with the histochemical (Fontana-Masson) and immunohistochemical (S100, HMB45) reactions established the diagnosis of prostatic blue nevus. The presence of melanin in prostatic tissue is an unusual aspect, being encountered three distinct lesions: blue nevus, melanosis and malignant melanoma. Recognition and correct classification of each of these three entities is fundamental, concerning the clinical and prognosis implications.
Collapse
Affiliation(s)
- Denisa Anderco
- Department of Pathology, Emergency County Hospital, Timisoara, Romania.
| | | | | | | | | |
Collapse
|
39
|
Guşet G, Costi S, Lazăr E, Dema A, Cornianu M, Vernic C, Păiuşan L. Expression of vascular endothelial growth factor (VEGF) and assessment of microvascular density with CD34 as prognostic markers for endometrial carcinoma. Rom J Morphol Embryol 2010; 51:677-682. [PMID: 21103625] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/30/2023]
Abstract
INTRODUCTION Angiogenesis plays an important role in the uncontrolled proliferation, invasion and metastasis of cancers. Increased microvessel density (MVD) is known to be associated with evolution and aggressiveness of the endometrial carcinoma (EC). The formation of new vessels depends on interactions between various hormones and growth factors. VEGF is one of the most known promoters of angiogenesis. MATERIAL AND METHODS In this study, we intend to evaluate the relation between MVD, the VEGF expression, and the clinicopathologic factors in patients with endometrial carcinoma. Formalin-fixed, paraffin-embedded tissue from 54 patients with EC were included. MVD was assessed with anti-CD34 in most intense areas of neovascularization. A semiquantitative scoring system was used to asses the intensity and degree of staining of VEGF. RESULTS MVD counts of patients with G1 EC was lower than patients with G2 and G3 EC. MVD counts of patients with stage I EC was lower as compared with stage II + III patients. There was no statistically significant difference between MVD counts in lymph node-negative and positive EC patients. The positive immunoreactions for VEGF were significantly more frequent in G1 EC in comparison to the patients with G2 + G3 EC. CONCLUSIONS MVD and VEGF are important indicators of a poor prognosis in patients with endometrial carcinoma.
Collapse
Affiliation(s)
- G Guşet
- Department of Obstetrics and Gynecology, County Hospital of Arad, Romania.
| | | | | | | | | | | | | |
Collapse
|
40
|
Bucuras V, Dema A, Taban S, Botoca M, Bardan R, Anderco D. UP-1.132: The Value and Limits of Alpha-Methyl-Acyl CoA Racemase (AMACR) in the Diagnosis of Prostate Cancer. Urology 2009. [DOI: 10.1016/j.urology.2009.07.579] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
41
|
Dema A, Tăban S, Herman I, Herman D, Lăzureanu C, Cornianu M, Lazăr E. Granular cell tumor of the penis shaft: case report and literature review. Chirurgia (Bucur) 2009; 104:359-362. [PMID: 19601473] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/28/2023]
Abstract
INTRODUCTION Granular cell tumors (GCT) are uncommon soft tissue neoplasms of presumed neural origin that rarely involve the male external genitalia. Penile lesions are distinctly uncommon with less than 20 cases reported till now. OBJECTIVE In the present paper we describe the clinicopathological and immunohistochemical findings in a case of GCT of the penis shaft in a 31-years-old man. RESULTS AND CONCLUSIONS On physical examination the patient was found to have a small ovoid mass, 20 x 10 mm in diameter, at the left postero-lateral area of the penis' base. The mass was firm on palpation with no fixation on the neighboring tissues. The lesion was completely excised under loco-regional anesthesia. The surgical specimen was an ovoid, gray-white, elastic mass, of 10 x 5 mm. Microscopically, the tumor was moderately cellular and was composed of polygonal-shaped cells with abundant granular eosinophilic cytoplasm. Tumor cells were disposed in nests, cords, and trabeculae and showed perineural invasion. The tumor presented bland cytological features with only focal slight nucleo-megaly. Mitotic activity was undetectable. The tumor cells showed diffuse immunohistochemical expression for S100 protein. At 6 month after surgery the patient was free of persistent/recurrent disease or metastatic spread of the tumor. We discuss the clinical, histo-immunohistochemical and therapeutical features of this unusual penile tumor, the single one encountered in the Department of Pathology from Timisoara County Hospital and, to our knowledge, the only one reported in the Romanian medical literature.
Collapse
Affiliation(s)
- A Dema
- Department of Pathology, University of Medicine and Pharmacy "V. Babeş", Timişoara, Romania.
| | | | | | | | | | | | | |
Collapse
|
42
|
Cornea R, Lazăr E, Dema A, Herman D. A nodular hyperplasia of the thymic epithelium (so-called microscopic thymoma). Rom J Morphol Embryol 2009; 50:729-731. [PMID: 19942974] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/28/2023]
Abstract
We investigate a case of nodular hyperplasia of the thymic epithelium which was incidentally, microscopically discovered. Macroscopically there was no sign of tumor and the thymus was surgically removed for the therapy of the clinical symptoms of the myasthenia gravis worsened in two years of evolution. Histological in a general appearance of an involuted thymic tissue, a small nodular epithelial proliferation was identified. The epithelial proliferation was classified as A-type in the WHO histological classification of the thymic epithelial tumors. Generally, these microscopic thymomas range from 0.2 mm to 0.4 mm in size that corresponds to our finding that measured 0.25/0.35 mm. This lesion was singular; on additional sections examined, we did not find other areas. Even so, there is a tight connection between the myasthenia gravis, thymomas and these microscopic thymomas, the development of a thymoma from this lesion has not been proven.
Collapse
Affiliation(s)
- R Cornea
- Department of Pathology, "Victor Babes" University of Medicine and Pharmacy, Timisoara, Romania.
| | | | | | | |
Collapse
|
43
|
Faur A, Lazăr E, Cornianu M, Dema A, Lăzureanu C, Mureşan A, Tăban S. Primary malignant non-Hodgkin's lymphomas of salivary glands. Rom J Morphol Embryol 2009; 50:693-699. [PMID: 19942968] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/28/2023]
Abstract
We evaluated the medical record of patients with salivary gland neoplasms diagnosed at Timisoara City Hospital from 2002 to 2009. A study has been carried out for seven years on 204 cases of salivary gland tumors and only two cases of salivary gland lymphomas were diagnosed. The two cases were females of 71- and 49-year-old, respectively. The formalin-fixed paraffin-embedded tissue samples were cut in 4 mum thick sections and stained with Hematoxylin and Eosin. The primary monoclonal antibodies for the immunohistochemical analysis were the followings: LCA (2B11, Dako), CD20 (L26, Dako), cytokeratin (MNF116, Dako), p53 (DQ-7, Dako), and PCNA (PC-10, Dako). The histopathology and immunohistochemistry suggested in the first case a low-grade diffuse large B-cell mucosa associated lymphoid tissue lymphoma and in the second case a high-grade extranodal marginal zone B-cell lymphoma.
Collapse
Affiliation(s)
- Alexandra Faur
- Department of Pathology, "Victor Babes" University of Medicine and Pharmacy, Timisoara, Romania.
| | | | | | | | | | | | | |
Collapse
|
44
|
Faur A, Lazăr E, Cornianu M, Dema A, Vidita CG, Găluşcan A. Warthin tumor: a curious entity--case reports and review of literature. Rom J Morphol Embryol 2009; 50:269-273. [PMID: 19434322] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/27/2023]
Abstract
Warthin tumor was first described in the American literature, by Aldred Warthin, in 1929, the pathologist who named this tumor papillary cystadenoma lymphomatosum, but since than it was also knew as adenolymphoma, cystadenolymphoma, and Warthin tumor. Because of its microscopically appearance and unknown origin, this tumor entity is still fascinating head and neck surgeons and pathologist. We evaluate the histopathological aspect of Warthin tumors using Hematoxylin-Eosin stain, and immunohistochemical and histological techniques. We reviewed the medical record of patients with salivary gland tumors diagnosed at County Hospital of Timisoara from 2002-2008. In six years, 22 cases with Warthin tumor were diagnosed and among them 17 men and five women, with average age 58.47. The analysis showed that 77.27% of Warthin tumors occurred in men, and the main histopathological aspect was with 50% epithelial component. The stromal component showed a prominent B-cell population by staining with CD20, and histological techniques for mucin were positive, and reticulin fibers were revealed while using Gordon-Sweets stain. The standard and the histological and immunohistochemical techniques highlighted the complex and variable microscopical appearance of Warthin tumor that the pathologist should consider when a diagnosis for this tumor is to be considered.
Collapse
Affiliation(s)
- Alexandra Faur
- Department of Pathology, Victor Babeş University of Medicine and Pharmacy, Timisoara, Romania.
| | | | | | | | | | | |
Collapse
|
45
|
Dema A, Tăban S, Cornianu M, Lazăr E, Herman D, Cepoiu R, Miculiţ F, Bârsăşteanu F, Oneţ D. [An unusual splenic tumor. Littoral cell angioma]. Chirurgia (Bucur) 2007; 102:739-743. [PMID: 18323239] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/26/2023]
Abstract
Littoral cell angioma is a rare splenic tumor which develops from specialised endothelial cells of the splenic red pulp. Numerous papers published since 1991 when the tumor was firstly described till now were focused on the radiologic characteristics of the lesion. This paper presents the clinical, imaging and morpho-immunohistochemical features of a littoral cell angioma diagnosed in a 51 year - old woman, to our knowledge, the first documented case in the Romanian medical literature. The lesion might be suspected on the basis of the clinical and imaging signs, but the diagnosis of certitude is provided by the gross and microscopic examination supplemented with immunohistochemical methods.
Collapse
Affiliation(s)
- A Dema
- Serviciul de Anatomie Patologică, Universitatea de Medicina şi Farmacie V. Babeş Timişoara.
| | | | | | | | | | | | | | | | | |
Collapse
|
46
|
Bucuras V, Dema A, Botoca M, Cumpanas A, Bardan R. UP-01.30. Urology 2006. [DOI: 10.1016/j.urology.2006.08.669] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
47
|
Baderca F, Lighezan R, Dema A, Alexa A, Raica M. Immunohistochemical expression of VEGF in normal human renal parenchyma. Rom J Morphol Embryol 2006; 47:315-22. [PMID: 17392976] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/14/2023]
Abstract
In the normal kidney, VEGF is constitutively expressed in podocytes and tubular epithelial cells of the renal cortex and medulla. The aim of this study was to determine distribution of VEGF in normal renal parenchyma using immunohistochemical methods. The study was retrospective, using normal kidneys samples taken from 28 patients with nephroureterectomy for different types of renal cell carcinomas. Sections were stained with routine Hematoxylin-Eosin method and immunohistochemically with anti-VEGF polyclonal antibody. All cases presented an intense immunoreaction in the cells lining the nephron tubular system, the higher immunoreaction intensity in the collecting and distal tubules, but weak or moderate in the proximal tubules. The Henle loop cells showed a negative immunoreaction. The immunoreaction was absent in most cells of the renal corpuscle. The cells lining the same tubule presented some variation of intensity, with large polygonal epithelial cells, bulging in the tubular lumen showing an intense cytoplasmic immunoreaction for VEGF. In the renal parenchyma adjacent to the tumor, we observed the same pattern of positive reaction distribution as in the nephron's epithelial tubular cells situated far from the tumor. Adjacent to the tumor proliferation front and in those cases with massive invasive features, we observed a partial depletion of VEGF in distal tubules, while the majority of collecting ducts remained intense positive. The VEGF immunostaining was significantly higher in the renal cortex than in the outer and respectively the inner medulla.
Collapse
Affiliation(s)
- Flavia Baderca
- Department of Histology, Victor Babeş University of Medicine and Pharmacy, Timişoara, Romania.
| | | | | | | | | |
Collapse
|
48
|
Baderca F, Lighezan R, Dema A, Alexa A, Raica M. Angiogenesis in urothelial tumors of the upper urinary tract. Rom J Morphol Embryol 2005; 46:263-8. [PMID: 16688360] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/09/2023]
Abstract
Angiogenesis is an essential process in the progression of malignant tumors. Tumors of the ureter and renal pelvis account for 5% of all urinary tract neoplasms. Little is known about angiogenesis in upper urinary tract urothelial tumors. We tried to demonstrate angiogenesis by using three endothelial markers CD31, CD34, von Willebrand factor and one pericytes marker (alpha-smooth muscle actin) in 26 cases. The pattern of CD31 immunolabelling was more complex and extensive than the vessel pattern shown by CD34 or factor VIII staining. In non-invasive tumors we observed that angiogenesis process is limited to connective tissue of tumor stroma. In the tumor area, the blood vessels stained with anti-CD31 had large lumen, thin walls and numerous branches, some of them being very thin. Pericyte covered vessels were branching of frequently into smaller, pericyte negative vessels.
Collapse
Affiliation(s)
- Flavia Baderca
- Department of Histology, Victor Babeş University of Medicine and Pharmacy, Timişoara, Romania.
| | | | | | | | | |
Collapse
|
49
|
Dema A, Tudose N. Immunohistochemical expression of prostate specific antigen (PSA) in benign and malignant tumors of the prostate. Rom J Morphol Embryol 1998; 44:93-100. [PMID: 15678849] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/01/2023]
Abstract
The immunohistochemical (IHC) expression of PSA in tissue fragments has been analysed in 25 patients with benign prostatic hypertrophy (BPH) and in 50 patients with prostatic carcinoma. The fragments were obtained by transurethral resection and transvesical adenomectomy. Morphology was studied by hematoxylin-eosin and Gömöri's trichrome staining. For immunohistochemical study anti-PSA monoclonal antibodies (DAKO, EPOS) were used. In BPH cases a positive reaction in the cytoplasm of secretory luminal cells was noticed; the reaction was negative in basal and urothelial cells, in foci of squamous metaplasia and in the cells of mucous gland metaplasia. All the classic types of prostatic carcinoma, regardless of the degree of differentiation showed positive reaction with various intensity and distribution. A positive focal reaction was noticed in two ductal carcinomas of endometrioid type. The reaction was negative in transitional, epidermoid and small cell carcinoma. Though less useful in differentiating benign from malignant lesions, this method may contribute to the differential diagnosis of particular forms of prostatic tumors.
Collapse
Affiliation(s)
- A Dema
- Dept. of Pathology, University of Medicine and Pharmacy of Timişoara
| | | |
Collapse
|
50
|
Dema A, Raica M, Tudose N. Prognostic significance of neuroendocrine differentiation in carcinoma of the prostate. Rom J Morphol Embryol 1996; 42:83-8. [PMID: 9038390] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/03/2023]
Abstract
Biopsies taken by core-needle biopsy and/or transurethral resection to 68 patients with prostatic neoplasia stage III and IV, were studied morphohistochemically. Morphological observations showed high incidence of mixed histopathological forms. The Churukian-Schenk and Garvey silver impregnations were used in order to identify associated neuroendocrine differentiations. Three cases presented monomorphic small cell proliferation which contained numerous argyrophilic cytoplasmic granulations. The prognosis in these cases was poor--the patients died because of neoplastic extension within 5 to 9 months following diagnosis. Neuroendocrine cells were identified in 15 cases, 6 of which presented a malignant pattern. Taking into consideration the hormonal resistance of malignant cells with argyrophilic granulations, the necessity of chemotherapy associated to hormonotherapy is discussed.
Collapse
Affiliation(s)
- A Dema
- University of Medicine and Pharmacy, Timişoara
| | | | | |
Collapse
|